NBAl的个人主页 - 老虎社区

NBAl

NBAl

暂无个人介绍

IP属地：未知

2关注

5粉丝

0主题

0勋章

2021-09-02

I scooped in few during the dip.

Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过 7%</blockquote>

2021-07-27

Will add more JD and NIO

Hot Chinese concept stocks resumed downward in premarket trading<blockquote>热门中国概念股在盘前交易中恢复下跌</blockquote>

2021-08-27

I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂

抱歉，原内容已删除

2021-08-02

Will enter when I have an opportunity. SEA is over valued at this time.

抱歉，原内容已删除

2021-08-09

Amazon and Apple are good buy, am not bullish o n FB considering countries legal restrictions and apple security features

抱歉，原内容已删除

2021-12-06

Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.

Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote>

2021-08-26

I was thinking of buying, now I will back off 😞

抱歉，原内容已删除

2021-07-26

Waiting for it to dip, I feel it is a value investmentas well

抱歉，原内容已删除

2021-07-30

Am a beginner, can I enter Amazon now.. guidance please

抱歉，原内容已删除

2021-11-15

Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582610336531043","uuid":"3582610336531043","gmtCreate":1619523668199,"gmtModify":1623066506738,"name":"NBAl","pinyin":"nbal","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":2,"tweetSize":54,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.29%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"80.52%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":698161349,"gmtCreate":1640319482440,"gmtModify":1640319814384,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Rivian has yet to prove and am&nbsp;not bullish on NIO yet as other Chinese EV’s are outperforming. Lucid (after it finds support)&nbsp;and Tesla (850 -880) range&nbsp;I will add them.","listText":"Rivian has yet to prove and am&nbsp;not bullish on NIO yet as other Chinese EV’s are outperforming. Lucid (after it finds support)&nbsp;and Tesla (850 -880) range&nbsp;I will add them.","text":"Rivian has yet to prove and am not bullish on NIO yet as other Chinese EV’s are outperforming. Lucid (after it finds support) and Tesla (850 -880) range I will add them.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698161349","repostId":"1128727196","repostType":2,"repost":{"id":"1128727196","kind":"news","pubTimestamp":1640305733,"share":"https://www.laohunote.com/m/news/1128727196?lang=zh_CN&edition=full","pubTime":"2021-12-24 08:28","market":"us","language":"en","title":"Down Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?<blockquote>Lucid、Rivian、蔚来和特斯拉会在2022年购买吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1128727196","media":"Motley Fool","summary":"These electric vehicle stocks are on sale, but that doesn't mean all are buys.","content":"<p><b>Key Points</b></p><p><blockquote><b>要点</b></blockquote></p><p> <ul>  <li>Lucid and Rivian are unproven but have a lot of potential.</li>  <li>Nio is down big from its high but just gave investors a jolt on Nio Day.</li>  <li>Tesla has a high valuation but is in its best shape ever.</li> </ul> December has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many&nbsp;growth stocks&nbsp;are actually down a lot for the year, and&nbsp;some are close to their 52-week lows.</p><p><blockquote><ul><li>Lucid和Rivian尚未得到证实，但有很大的潜力。</li><li>蔚来较高点大幅下跌，但在蔚来日给投资者带来了冲击。</li><li>特斯拉估值很高，但处于有史以来最好的状态。</li></ul>到目前为止，12月是一个疯狂的月份，因为主要股指每天都有大幅波动。虽然一些股票在历史高点附近徘徊，但许多成长型股票实际上今年下跌了很多，有些股票接近 52 周低点。</blockquote></p><p> <b>Lucid Group</b>(NASDAQ:LCID),<b>Rivian Automotive</b>(NASDAQ:RIVN),<b>Nio</b>(NYSE:NIO), and&nbsp;<b>Tesla</b>(NASDAQ:TSLA)&nbsp;are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.</p><p><blockquote><b>Lucid集团</b>（纳斯达克代码：LCID），<b>Rivian汽车</b>（纳斯达克股票代码：RIVN）<b>蔚来</b>（纽约证券交易所股票代码：NIO），以及<b>特斯拉</b>（纳斯达克股票代码：TSLA）是四只备受瞩目的电动汽车 (EV) 股票，均较高点下跌 25% 或更多。以下是每种产品的内幕，以及现在最值得购买的产品。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a625e7f56da175a14e5d6cbfcdce47c\" tg-width=\"2000\" tg-height=\"1000\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: NIO.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：蔚来。</span></p></blockquote></p><p> <b>Lucid has some serious upside</b></p><p><blockquote><b>Lucid 有一些很大的优势</b></blockquote></p><p> Share prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid&nbsp;delivered on its promises in 2021&nbsp;by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet&nbsp;recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents&nbsp;that was issued on Dec. 3&nbsp;and a controversial senior note offering, have taken a toll on Lucid stock of late.</p><p><blockquote>Lucid Group 的股价较高点下跌了 38%，这家新兴电动轿车公司面临着充满挑战的 2022 年。Lucid 在 2021 年兑现了其承诺，扩大了制造工厂、上市并筹集了现金、进入大规模生产并开始向客户交付。然而，最近发生的事件，最引人注目的是美国证券交易委员会 (SEC) 于 12 月 3 日发布的文件要求以及有争议的优先票据发行，最近对 Lucid 的股价造成了影响。</blockquote></p><p> Despite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently&nbsp;sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a&nbsp;staple in the luxury sedan market&nbsp;over time.</p><p><blockquote>尽管有负面报道，但有理由相信 Lucid 可能是一只值得长期持有的优秀股票。对于 Lucid 来说，发行优先票据的时机非常好，该公司的股票估值为每股 54.78 美元（比撰写本文时的股价溢价 37%）。它还为公司提供了加快生产、扩大产能和满足目前超过 17,000 个预订的客户需求所需的现金。鉴于其令人难以置信的电池技术，随着时间的推移，Lucid 可能会成为豪华轿车市场的主要产品。</blockquote></p><p> <b>Rivian isn't worth $86 billion...yet</b></p><p><blockquote><b>Rivian还不值 860 亿美元……还没有</b></blockquote></p><p> Rivian has seen its stock sink as the&nbsp;honeymoon period after its initial public offering&nbsp;(IPO) draws to a close. In fact, Rivian's share price&nbsp;fell over 10%&nbsp;on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.</p><p><blockquote>随着首次公开募股 (IPO) 后的蜜月期接近尾声，Rivian的股价下跌。事实上，Rivian 公布 2021 年第三季度财报后，其股价在 12 月 17 日下跌超过 10%，这是其作为上市公司的第一份财报。低于预期的客户交付量、超出预期的亏损，以及需要大量资金才能将其制造和充电网络扩大到Rivian希望的规模的严酷现实，加在一起，导致了一个总体令人失望的季度。然而，Rivian 的预订数量正在以惊人的速度增长——事实上，比 Lucid 的要快得多。然而，在Rivian能够设定目标并达到或超过目标之前，很难相信该公司的发展轨迹，更不用说Rivian 860亿美元的估值了。</blockquote></p><p> <b>Down but not out</b></p><p><blockquote><b>向下但未向外</b></blockquote></p><p> No stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.</p><p><blockquote>这份名单上没有一只股票比中国汽车制造商蔚来更偏离其高点，该公司股价下跌了 55%，目前徘徊在 52 周低点附近。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3055b147aea5ec316e8f30352bbd489d\" tg-width=\"720\" tg-height=\"516\" width=\"100%\" height=\"auto\"><span>LCID DATA BY YCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCHARTS提供的LCID数据</span></p></blockquote></p><p> It wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.</p><p><blockquote>就在不久前，蔚来还获得了与 Lucid 和Rivian在过去几个月相同的关注。但最近，它发现自己处于聚光灯之外，或者因为负面的原因而短暂地出现在聚光灯下。</blockquote></p><p> Nio has been mass-producing&nbsp;electric cars&nbsp;for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an&nbsp;uncertain growth plan in Europe&nbsp;are all headwinds facing Nio right now. What's more, the SEC is&nbsp;tightening its grip&nbsp;on foreign companies like Nio.</p><p><blockquote>蔚来大规模生产电动汽车已经有几年了，并且正在成为该领域的老牌参与者。不一致的生产数字和不确定的欧洲增长计划都是蔚来目前面临的阻力。更重要的是，美国证券交易委员会正在加强对蔚来等外国公司的控制。</blockquote></p><p> However, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.</p><p><blockquote>然而，蔚来于 12 月 18 日举行了备受期待的蔚来日，推出了新款 ET5 中型轿车并发布了各种公告。蔚来并不缺乏创新，可能会成为一个伟大的长期赢家。</blockquote></p><p> <b>Firing on all electric motors</b></p><p><blockquote><b>所有电动机点火</b></blockquote></p><p> Tesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.</p><p><blockquote>由于投资者正在努力应对许多成长型股票的估值担忧，特斯拉股价较高点“仅”下跌了 25%。特斯拉不再是以前那家无利可图、不稳定的公司，但它的定价非常完美，市销率为 22.5，市盈率为 301.8。</blockquote></p><p> Despite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are&nbsp;reasons to like the company for years to come.</p><p><blockquote>尽管估值很高，但特斯拉公司有很多值得喜欢的地方。其行业领先的营业利润率、令人印象深刻的增长、多元化的业务以及在不断增长的电动汽车行业中的市场领先地位是未来几年喜欢该公司的原因。</blockquote></p><p> <b>An EV basket for 2022</b></p><p><blockquote><b>2022 年电动汽车篮子</b></blockquote></p><p></p><p> Two ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a&nbsp;50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.</p><p><blockquote>应对顶级电动汽车股票抛售的两种方法是篮子策略和观望策略。比如说，投资于Lucid和特斯拉50/50的股份，甚至是名单上所有四家公司的均等股份，可以接触到市场的多个方面，同时限制任何一家公司对你的投资组合造成的损害。</blockquote></p><p> However, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.</p><p><blockquote>然而，我们很有可能距离 Lucid、Rivian或蔚来的持续盈利还需要数年时间。对于许多投资者来说，简单地等待电动汽车领域成熟，然后选出赢家可能会留下一些钱，但这可能是一个更安全且仍然有回报的赌注。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Down Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?<blockquote>Lucid、Rivian、蔚来和特斯拉会在2022年购买吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDown Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?<blockquote>Lucid、Rivian、蔚来和特斯拉会在2022年购买吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-24 08:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Key Points</b></p><p><blockquote><b>要点</b></blockquote></p><p> <ul>  <li>Lucid and Rivian are unproven but have a lot of potential.</li>  <li>Nio is down big from its high but just gave investors a jolt on Nio Day.</li>  <li>Tesla has a high valuation but is in its best shape ever.</li> </ul> December has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many&nbsp;growth stocks&nbsp;are actually down a lot for the year, and&nbsp;some are close to their 52-week lows.</p><p><blockquote><ul><li>Lucid和Rivian尚未得到证实，但有很大的潜力。</li><li>蔚来较高点大幅下跌，但在蔚来日给投资者带来了冲击。</li><li>特斯拉估值很高，但处于有史以来最好的状态。</li></ul>到目前为止，12月是一个疯狂的月份，因为主要股指每天都有大幅波动。虽然一些股票在历史高点附近徘徊，但许多成长型股票实际上今年下跌了很多，有些股票接近 52 周低点。</blockquote></p><p> <b>Lucid Group</b>(NASDAQ:LCID),<b>Rivian Automotive</b>(NASDAQ:RIVN),<b>Nio</b>(NYSE:NIO), and&nbsp;<b>Tesla</b>(NASDAQ:TSLA)&nbsp;are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.</p><p><blockquote><b>Lucid集团</b>（纳斯达克代码：LCID），<b>Rivian汽车</b>（纳斯达克股票代码：RIVN）<b>蔚来</b>（纽约证券交易所股票代码：NIO），以及<b>特斯拉</b>（纳斯达克股票代码：TSLA）是四只备受瞩目的电动汽车 (EV) 股票，均较高点下跌 25% 或更多。以下是每种产品的内幕，以及现在最值得购买的产品。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a625e7f56da175a14e5d6cbfcdce47c\" tg-width=\"2000\" tg-height=\"1000\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: NIO.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：蔚来。</span></p></blockquote></p><p> <b>Lucid has some serious upside</b></p><p><blockquote><b>Lucid 有一些很大的优势</b></blockquote></p><p> Share prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid&nbsp;delivered on its promises in 2021&nbsp;by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet&nbsp;recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents&nbsp;that was issued on Dec. 3&nbsp;and a controversial senior note offering, have taken a toll on Lucid stock of late.</p><p><blockquote>Lucid Group 的股价较高点下跌了 38%，这家新兴电动轿车公司面临着充满挑战的 2022 年。Lucid 在 2021 年兑现了其承诺，扩大了制造工厂、上市并筹集了现金、进入大规模生产并开始向客户交付。然而，最近发生的事件，最引人注目的是美国证券交易委员会 (SEC) 于 12 月 3 日发布的文件要求以及有争议的优先票据发行，最近对 Lucid 的股价造成了影响。</blockquote></p><p> Despite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently&nbsp;sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a&nbsp;staple in the luxury sedan market&nbsp;over time.</p><p><blockquote>尽管有负面报道，但有理由相信 Lucid 可能是一只值得长期持有的优秀股票。对于 Lucid 来说，发行优先票据的时机非常好，该公司的股票估值为每股 54.78 美元（比撰写本文时的股价溢价 37%）。它还为公司提供了加快生产、扩大产能和满足目前超过 17,000 个预订的客户需求所需的现金。鉴于其令人难以置信的电池技术，随着时间的推移，Lucid 可能会成为豪华轿车市场的主要产品。</blockquote></p><p> <b>Rivian isn't worth $86 billion...yet</b></p><p><blockquote><b>Rivian还不值 860 亿美元……还没有</b></blockquote></p><p> Rivian has seen its stock sink as the&nbsp;honeymoon period after its initial public offering&nbsp;(IPO) draws to a close. In fact, Rivian's share price&nbsp;fell over 10%&nbsp;on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.</p><p><blockquote>随着首次公开募股 (IPO) 后的蜜月期接近尾声，Rivian的股价下跌。事实上，Rivian 公布 2021 年第三季度财报后，其股价在 12 月 17 日下跌超过 10%，这是其作为上市公司的第一份财报。低于预期的客户交付量、超出预期的亏损，以及需要大量资金才能将其制造和充电网络扩大到Rivian希望的规模的严酷现实，加在一起，导致了一个总体令人失望的季度。然而，Rivian 的预订数量正在以惊人的速度增长——事实上，比 Lucid 的要快得多。然而，在Rivian能够设定目标并达到或超过目标之前，很难相信该公司的发展轨迹，更不用说Rivian 860亿美元的估值了。</blockquote></p><p> <b>Down but not out</b></p><p><blockquote><b>向下但未向外</b></blockquote></p><p> No stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.</p><p><blockquote>这份名单上没有一只股票比中国汽车制造商蔚来更偏离其高点，该公司股价下跌了 55%，目前徘徊在 52 周低点附近。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3055b147aea5ec316e8f30352bbd489d\" tg-width=\"720\" tg-height=\"516\" width=\"100%\" height=\"auto\"><span>LCID DATA BY YCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCHARTS提供的LCID数据</span></p></blockquote></p><p> It wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.</p><p><blockquote>就在不久前，蔚来还获得了与 Lucid 和Rivian在过去几个月相同的关注。但最近，它发现自己处于聚光灯之外，或者因为负面的原因而短暂地出现在聚光灯下。</blockquote></p><p> Nio has been mass-producing&nbsp;electric cars&nbsp;for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an&nbsp;uncertain growth plan in Europe&nbsp;are all headwinds facing Nio right now. What's more, the SEC is&nbsp;tightening its grip&nbsp;on foreign companies like Nio.</p><p><blockquote>蔚来大规模生产电动汽车已经有几年了，并且正在成为该领域的老牌参与者。不一致的生产数字和不确定的欧洲增长计划都是蔚来目前面临的阻力。更重要的是，美国证券交易委员会正在加强对蔚来等外国公司的控制。</blockquote></p><p> However, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.</p><p><blockquote>然而，蔚来于 12 月 18 日举行了备受期待的蔚来日，推出了新款 ET5 中型轿车并发布了各种公告。蔚来并不缺乏创新，可能会成为一个伟大的长期赢家。</blockquote></p><p> <b>Firing on all electric motors</b></p><p><blockquote><b>所有电动机点火</b></blockquote></p><p> Tesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.</p><p><blockquote>由于投资者正在努力应对许多成长型股票的估值担忧，特斯拉股价较高点“仅”下跌了 25%。特斯拉不再是以前那家无利可图、不稳定的公司，但它的定价非常完美，市销率为 22.5，市盈率为 301.8。</blockquote></p><p> Despite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are&nbsp;reasons to like the company for years to come.</p><p><blockquote>尽管估值很高，但特斯拉公司有很多值得喜欢的地方。其行业领先的营业利润率、令人印象深刻的增长、多元化的业务以及在不断增长的电动汽车行业中的市场领先地位是未来几年喜欢该公司的原因。</blockquote></p><p> <b>An EV basket for 2022</b></p><p><blockquote><b>2022 年电动汽车篮子</b></blockquote></p><p></p><p> Two ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a&nbsp;50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.</p><p><blockquote>应对顶级电动汽车股票抛售的两种方法是篮子策略和观望策略。比如说，投资于Lucid和特斯拉50/50的股份，甚至是名单上所有四家公司的均等股份，可以接触到市场的多个方面，同时限制任何一家公司对你的投资组合造成的损害。</blockquote></p><p> However, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.</p><p><blockquote>然而，我们很有可能距离 Lucid、Rivian或蔚来的持续盈利还需要数年时间。对于许多投资者来说，简单地等待电动汽车领域成熟，然后选出赢家可能会留下一些钱，但这可能是一个更安全且仍然有回报的赌注。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","TSLA":"特斯拉","RIVN":"Rivian Automotive, Inc.","LCID":"Lucid Group Inc"},"source_url":"https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128727196","content_text":"Key Points\n\nLucid and Rivian are unproven but have a lot of potential.\nNio is down big from its high but just gave investors a jolt on Nio Day.\nTesla has a high valuation but is in its best shape ever.\n\nDecember has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many growth stocks are actually down a lot for the year, and some are close to their 52-week lows.\nLucid Group(NASDAQ:LCID),Rivian Automotive(NASDAQ:RIVN),Nio(NYSE:NIO), and Tesla(NASDAQ:TSLA) are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.\nIMAGE SOURCE: NIO.\nLucid has some serious upside\nShare prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid delivered on its promises in 2021 by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents that was issued on Dec. 3 and a controversial senior note offering, have taken a toll on Lucid stock of late.\nDespite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a staple in the luxury sedan market over time.\nRivian isn't worth $86 billion...yet\nRivian has seen its stock sink as the honeymoon period after its initial public offering (IPO) draws to a close. In fact, Rivian's share price fell over 10% on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.\nDown but not out\nNo stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.\nLCID DATA BY YCHARTS\nIt wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.\nNio has been mass-producing electric cars for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an uncertain growth plan in Europe are all headwinds facing Nio right now. What's more, the SEC is tightening its grip on foreign companies like Nio.\nHowever, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.\nFiring on all electric motors\nTesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.\nDespite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are reasons to like the company for years to come.\nAn EV basket for 2022\nTwo ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a 50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.\nHowever, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.","news_type":1,"symbols_score_info":{"NIO":0.9,"RIVN":0.9,"LCID":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":4837,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583106134648492","authorId":"3583106134648492","name":"Frosty4ever","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3583106134648492","idStr":"3583106134648492"},"content":"ford $Tesla Motors(TSLA)$ barring black swan event for short term unlikely to go below 900. Elon is almost done selling. less opportunity for shorts.","text":"ford $Tesla Motors(TSLA)$ barring black swan event for short term unlikely to go below 900. Elon is almost done selling. less opportunity for shorts.","html":"ford $Tesla Motors(TSLA)$ barring black swan event for short term unlikely to go below 900. Elon is almost done selling. less opportunity for shorts."}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693822211,"gmtCreate":1640004466150,"gmtModify":1640004466273,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Invest money that we wouldn’t need for next 3years atleast.","listText":"Invest money that we wouldn’t need for next 3years atleast.","text":"Invest money that we wouldn’t need for next 3years atleast.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693822211","repostId":"1160299527","repostType":4,"isVote":1,"tweetType":1,"viewCount":4373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693901232,"gmtCreate":1639956847455,"gmtModify":1639956847539,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Wow, if she was so convinced about the strategyshe wouldn’t have use pump and dump.. it is like catching a falling knife and hope the wounds will heal one day.","listText":"Wow, if she was so convinced about the strategyshe wouldn’t have use pump and dump.. it is like catching a falling knife and hope the wounds will heal one day.","text":"Wow, if she was so convinced about the strategyshe wouldn’t have use pump and dump.. it is like catching a falling knife and hope the wounds will heal one day.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693901232","repostId":"2192708619","repostType":4,"repost":{"id":"2192708619","kind":"highlight","pubTimestamp":1639954209,"share":"https://www.laohunote.com/m/news/2192708619?lang=zh_CN&edition=full","pubTime":"2021-12-20 06:50","market":"us","language":"en","title":"Cathie Wood says stocks have corrected into 'deep value territory' and won't let benchmarks 'hold our strategies hostage'<blockquote>凯西·伍德表示，股市已回调至“深度价值区域”，不会让基准“挟持我们的策略”</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2192708619","media":"MarketWatch","summary":"ARK Invest founder Cathie Wood offered the latest defense of the once-highflying, disruptive innovat","content":"<p>ARK Invest founder Cathie Wood offered the latest defense of the once-highflying, disruptive innovation strategies that had made her suite of exchange-traded funds among the most popular, and best-performing, on Wall Street in 2020.</p><p><blockquote>ARK Invest 创始人凯西·伍德 (Cathie Wood) 为曾经高歌猛进的颠覆性创新战略进行了最新辩护，这些战略使她的交易所交易基金套件成为 2020 年华尔街最受欢迎、表现最好的基金之一。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5e17c2568a6dc81e7e3573ede78dcfb0\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Patrick T. Fallon/AFP/Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>帕特里克·T·法伦/法新社/盖蒂图片社</span></p></blockquote></p><p> In a Friday evening blog post, Wood said that despite a brutal stretch that has compelled the operators of the ARK Invest ETFs, including the flagship Ark Innovation&nbsp;fund, to do some soul-searching, the fund manager is sticking to her game plan.</p><p><blockquote>伍德在周五晚上的一篇博客文章中表示，尽管经历了一段残酷的时期，迫使 Ark Invest ETF 的运营商（包括旗舰 Ark Innovation fund）进行一些反省，但该基金经理仍坚持她的游戏计划。</blockquote></p><p>   “‘With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years.’”  “We won’t let benchmarks and tracking errors hold our strategies hostage to the existing world order,” Wood wrote. She described the success of the ARK ETFs as one not solely bolstered by fervor for “stay at home” investment opportunities, amid the COVID pandemic, but rooted in identifying paradigm-shifting innovation, from blockchain and bitcoin&nbsp;to electric vehicles.</p><p><blockquote>“我们对这些平台的投资期限为五年，我们的预测表明，我们目前的策略在未来五年内可实现 30-40% 的复合年回报率。“伍德写道：”我们不会让基准和跟踪误差成为我们战略的人质。她认为，ARK ETF 的成功不仅得益于在 COVID 大流行期间人们对 “足不出户 ”投资机会的热情，而且还植根于识别从区块链和比特币到电动汽车的范式转变创新。</blockquote></p><p> “Critical to investment success will be moving to the right side of change, avoiding industries and companies caught in the crosshairs of ‘creative destruction’ and embracing those on the leading edge of ‘disruptive innovation,'” Wood wrote.</p><p><blockquote>“伍德写道：”投资成功的关键在于走向变革的正确一边，避开陷入'创造性破坏'十字路口的行业和公司，拥抱那些处于'颠覆性创新'前沿的行业和公司。</blockquote></p><p> On Friday, ARK Innovation ended the session up nearly 6% and produced its second straight sharp weekly gain, up 1.1%, following a 1.8% advance in the prior week. The advance for ARK Innovation still leaves the actively managed fund down nearly 22% in the year to date, as the broader S&amp;P 500,the Dow Jones Industrial Average&nbsp;and the technology Nasdaq Composite Index&nbsp;have faced whipsawing volatility derived primarily from concerns about more transmissible strains of COVID, surging inflation and global monetary policy’s reaction to those pricing pressures. Year-to-date the S&amp;P 500 index is up 864.57 points or 23.02%.</p><p><blockquote>周五，ARK Innovation 收盘上涨近 6%，连续第二周大幅上涨 1.1%，此前一周上涨 1.8%。今年迄今为止，ARK Innovation 的上涨仍导致这只主动管理型基金下跌近 22%，因为更广泛的标准普尔 500 指数、道琼斯工业平均指数和纳斯达克科技综合指数都面临着剧烈的波动，这主要源于对更容易传播的 COVID 病毒株、飙升的通货膨胀以及全球货币政策对这些定价压力的反应的担忧。今年迄今，标普500指数上涨864.57点，涨幅23.02%。</blockquote></p><p> ARK’s seven ETFs returned an average of 141% in 2020, on the back of gains from companies such as&nbsp;<b>Tesla Inc.</b>,and&nbsp;<b>Teladoc Health Inc</b>.,&nbsp;making Wood the toast of Wall Street. But those funds, focused primarily on companies that aren’t yet profitable, have been limping lower since hitting a peak back in February, and their woeful performance has raised questions about the prospects for the ETFs in the months and years to come.</p><p><blockquote>ARK 的七只 ETF 在 2020 年的平均回报率为 141%，这得益于以下公司的收益。<b>特斯拉公司。</b>,和<b>泰拉多克健康公司</b>.，让木材成为华尔街的烤面包。但这些主要投资于尚未盈利的公司的基金，自 2 月份达到峰值以来一直在走低，其糟糕的表现让人对 ETF 未来几个月和几年的前景产生了质疑。</blockquote></p><p> Wood urged investors to maintain their support of the ARK complex and said that maintaining a long-term, five-year time horizon would be the best way to judge the fund manager’s true performance.</p><p><blockquote>伍德敦促投资者继续支持方舟综合体，并表示维持五年的长期时间范围将是判断基金经理真实业绩的最佳方式。</blockquote></p><p> “With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years,” the ARK CEO wrote.</p><p><blockquote>“方舟首席执行官写道：”在五年的投资期限内，我们对这些平台的预测表明，我们目前的策略可以在未来五年内实现 30-40% 的复合年回报率。</blockquote></p><p> “In other words, if our research is correct—and I believe that our research on innovation is the best in the financial world—then our strategies will triple to quintuple in value over the next five years,”&nbsp;Wood added.</p><p><blockquote>“换句话说，如果我们的研究是正确的--我相信我们对创新的研究是金融界最好的--那么在未来五年内，我们的战略价值将增加两到五倍，”伍德补充道。</blockquote></p><p> The ARK founder also made the case that the Nasdaq and S&amp;P 500 could be the bigger disappointment to return-eager investors in the longer-term because they are more overvalued than the disruptive investments that comprise her funds.</p><p><blockquote>这位方舟创始人还表示，从长远来看，纳斯达克和标普500可能会让渴望回报的投资者更失望，因为它们比构成她基金的颠覆性投资更被高估。</blockquote></p><p> “Unlike many innovation-related stocks, equity benchmarks are selling at record high prices and near record high valuations, 26x for the S&amp;P 500 and 127x for the Nasdaq on a trailing twelve-month basis,” Wood wrote.</p><p><blockquote>“伍德写道：”与许多与创新相关的股票不同，股票基准正以创纪录的高价和接近创纪录的高估值出售，过去 12 个月标普500的估值是 26 倍，纳斯达克的估值是 127 倍。</blockquote></p><p> She said that the “five major innovation platforms which involve 14 technologies are likely to transform the existing world order and that so-called tried and true investment strategies “will disappoint during the next five to ten years as DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain technology scale and converge.”</p><p><blockquote>她说，“涉及 14 项技术的五大创新平台很可能会改变现有的世界秩序，而所谓的屡试不爽的投资策略 “将在未来五到十年内令人失望，因为 DNA 测序、机器人、储能、人工智能和区块链技术的规模化和融合”。</blockquote></p><p> Wood also made the case that the so-called wall of worry, with inflation fears representing perhaps the biggest concern, provided an ideal backdrop for further advances in innovation stocks in the longer run because the dot-com markets of the late-1990s weren’t properly buffeted by investor concerns. The thinking is that “walls of worry” tend to limit market euphoria.</p><p><blockquote>伍德还认为，所谓的担忧墙（通胀担忧也许是最大的担忧）为创新股的长期进一步上涨提供了理想的背景，因为 20 世纪 90 年代末的互联网市场并没有受到投资者担忧的适当冲击。人们认为，“担忧之墙”往往会限制市场的兴奋情绪。</blockquote></p><p> “In our view, the wall of worry built on the back of high multiple stocks bodes well for equities in the innovation space,” she wrote. “No wall of worry existed or tested the equity market in 1999. This time around, the wall of worry has scaled to enormous heights,” Wood said.</p><p><blockquote>“她写道：”在我们看来，建立在高倍数股票背后的担忧之墙对创新领域的股票来说是个好兆头。“1999 年，担忧之墙并不存在，也没有考验股市。这一次，担忧之墙已经攀升到了极高的高度，”伍德说。</blockquote></p><p> On the macroeconomic front, Wood said that deflation, rather than inflation, could be a bigger problem for markets in the coming months.</p><p><blockquote>在宏观经济方面，伍德表示，未来几个月市场面临的问题可能是通货紧缩而不是通货膨胀。</blockquote></p><p></p><p> “That said, my conviction is growing that the bigger surprise to the markets will be price deflation – both cyclical and secular – and that, after collapsing this year, higher multiple stocks could turn around dramatically during the next year,” she wrote.</p><p><blockquote>“她写道：”尽管如此，我越来越相信，给市场带来更大的惊喜将是价格通缩--包括周期性的和长期性的--而且，在今年崩盘之后，多只股票可能会在明年出现戏剧性的好转。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood says stocks have corrected into 'deep value territory' and won't let benchmarks 'hold our strategies hostage'<blockquote>凯西·伍德表示，股市已回调至“深度价值区域”，不会让基准“挟持我们的策略”</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood says stocks have corrected into 'deep value territory' and won't let benchmarks 'hold our strategies hostage'<blockquote>凯西·伍德表示，股市已回调至“深度价值区域”，不会让基准“挟持我们的策略”</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-12-20 06:50</span>\n</p>\n</h4>\n</header>\n<article>\n<p>ARK Invest founder Cathie Wood offered the latest defense of the once-highflying, disruptive innovation strategies that had made her suite of exchange-traded funds among the most popular, and best-performing, on Wall Street in 2020.</p><p><blockquote>ARK Invest 创始人凯西·伍德 (Cathie Wood) 为曾经高歌猛进的颠覆性创新战略进行了最新辩护，这些战略使她的交易所交易基金套件成为 2020 年华尔街最受欢迎、表现最好的基金之一。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5e17c2568a6dc81e7e3573ede78dcfb0\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Patrick T. Fallon/AFP/Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>帕特里克·T·法伦/法新社/盖蒂图片社</span></p></blockquote></p><p> In a Friday evening blog post, Wood said that despite a brutal stretch that has compelled the operators of the ARK Invest ETFs, including the flagship Ark Innovation&nbsp;fund, to do some soul-searching, the fund manager is sticking to her game plan.</p><p><blockquote>伍德在周五晚上的一篇博客文章中表示，尽管经历了一段残酷的时期，迫使 Ark Invest ETF 的运营商（包括旗舰 Ark Innovation fund）进行一些反省，但该基金经理仍坚持她的游戏计划。</blockquote></p><p>   “‘With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years.’”  “We won’t let benchmarks and tracking errors hold our strategies hostage to the existing world order,” Wood wrote. She described the success of the ARK ETFs as one not solely bolstered by fervor for “stay at home” investment opportunities, amid the COVID pandemic, but rooted in identifying paradigm-shifting innovation, from blockchain and bitcoin&nbsp;to electric vehicles.</p><p><blockquote>“我们对这些平台的投资期限为五年，我们的预测表明，我们目前的策略在未来五年内可实现 30-40% 的复合年回报率。“伍德写道：”我们不会让基准和跟踪误差成为我们战略的人质。她认为，ARK ETF 的成功不仅得益于在 COVID 大流行期间人们对 “足不出户 ”投资机会的热情，而且还植根于识别从区块链和比特币到电动汽车的范式转变创新。</blockquote></p><p> “Critical to investment success will be moving to the right side of change, avoiding industries and companies caught in the crosshairs of ‘creative destruction’ and embracing those on the leading edge of ‘disruptive innovation,'” Wood wrote.</p><p><blockquote>“伍德写道：”投资成功的关键在于走向变革的正确一边，避开陷入'创造性破坏'十字路口的行业和公司，拥抱那些处于'颠覆性创新'前沿的行业和公司。</blockquote></p><p> On Friday, ARK Innovation ended the session up nearly 6% and produced its second straight sharp weekly gain, up 1.1%, following a 1.8% advance in the prior week. The advance for ARK Innovation still leaves the actively managed fund down nearly 22% in the year to date, as the broader S&amp;P 500,the Dow Jones Industrial Average&nbsp;and the technology Nasdaq Composite Index&nbsp;have faced whipsawing volatility derived primarily from concerns about more transmissible strains of COVID, surging inflation and global monetary policy’s reaction to those pricing pressures. Year-to-date the S&amp;P 500 index is up 864.57 points or 23.02%.</p><p><blockquote>周五，ARK Innovation 收盘上涨近 6%，连续第二周大幅上涨 1.1%，此前一周上涨 1.8%。今年迄今为止，ARK Innovation 的上涨仍导致这只主动管理型基金下跌近 22%，因为更广泛的标准普尔 500 指数、道琼斯工业平均指数和纳斯达克科技综合指数都面临着剧烈的波动，这主要源于对更容易传播的 COVID 病毒株、飙升的通货膨胀以及全球货币政策对这些定价压力的反应的担忧。今年迄今，标普500指数上涨864.57点，涨幅23.02%。</blockquote></p><p> ARK’s seven ETFs returned an average of 141% in 2020, on the back of gains from companies such as&nbsp;<b>Tesla Inc.</b>,and&nbsp;<b>Teladoc Health Inc</b>.,&nbsp;making Wood the toast of Wall Street. But those funds, focused primarily on companies that aren’t yet profitable, have been limping lower since hitting a peak back in February, and their woeful performance has raised questions about the prospects for the ETFs in the months and years to come.</p><p><blockquote>ARK 的七只 ETF 在 2020 年的平均回报率为 141%，这得益于以下公司的收益。<b>特斯拉公司。</b>,和<b>泰拉多克健康公司</b>.，让木材成为华尔街的烤面包。但这些主要投资于尚未盈利的公司的基金，自 2 月份达到峰值以来一直在走低，其糟糕的表现让人对 ETF 未来几个月和几年的前景产生了质疑。</blockquote></p><p> Wood urged investors to maintain their support of the ARK complex and said that maintaining a long-term, five-year time horizon would be the best way to judge the fund manager’s true performance.</p><p><blockquote>伍德敦促投资者继续支持方舟综合体，并表示维持五年的长期时间范围将是判断基金经理真实业绩的最佳方式。</blockquote></p><p> “With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years,” the ARK CEO wrote.</p><p><blockquote>“方舟首席执行官写道：”在五年的投资期限内，我们对这些平台的预测表明，我们目前的策略可以在未来五年内实现 30-40% 的复合年回报率。</blockquote></p><p> “In other words, if our research is correct—and I believe that our research on innovation is the best in the financial world—then our strategies will triple to quintuple in value over the next five years,”&nbsp;Wood added.</p><p><blockquote>“换句话说，如果我们的研究是正确的--我相信我们对创新的研究是金融界最好的--那么在未来五年内，我们的战略价值将增加两到五倍，”伍德补充道。</blockquote></p><p> The ARK founder also made the case that the Nasdaq and S&amp;P 500 could be the bigger disappointment to return-eager investors in the longer-term because they are more overvalued than the disruptive investments that comprise her funds.</p><p><blockquote>这位方舟创始人还表示，从长远来看，纳斯达克和标普500可能会让渴望回报的投资者更失望，因为它们比构成她基金的颠覆性投资更被高估。</blockquote></p><p> “Unlike many innovation-related stocks, equity benchmarks are selling at record high prices and near record high valuations, 26x for the S&amp;P 500 and 127x for the Nasdaq on a trailing twelve-month basis,” Wood wrote.</p><p><blockquote>“伍德写道：”与许多与创新相关的股票不同，股票基准正以创纪录的高价和接近创纪录的高估值出售，过去 12 个月标普500的估值是 26 倍，纳斯达克的估值是 127 倍。</blockquote></p><p> She said that the “five major innovation platforms which involve 14 technologies are likely to transform the existing world order and that so-called tried and true investment strategies “will disappoint during the next five to ten years as DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain technology scale and converge.”</p><p><blockquote>她说，“涉及 14 项技术的五大创新平台很可能会改变现有的世界秩序，而所谓的屡试不爽的投资策略 “将在未来五到十年内令人失望，因为 DNA 测序、机器人、储能、人工智能和区块链技术的规模化和融合”。</blockquote></p><p> Wood also made the case that the so-called wall of worry, with inflation fears representing perhaps the biggest concern, provided an ideal backdrop for further advances in innovation stocks in the longer run because the dot-com markets of the late-1990s weren’t properly buffeted by investor concerns. The thinking is that “walls of worry” tend to limit market euphoria.</p><p><blockquote>伍德还认为，所谓的担忧墙（通胀担忧也许是最大的担忧）为创新股的长期进一步上涨提供了理想的背景，因为 20 世纪 90 年代末的互联网市场并没有受到投资者担忧的适当冲击。人们认为，“担忧之墙”往往会限制市场的兴奋情绪。</blockquote></p><p> “In our view, the wall of worry built on the back of high multiple stocks bodes well for equities in the innovation space,” she wrote. “No wall of worry existed or tested the equity market in 1999. This time around, the wall of worry has scaled to enormous heights,” Wood said.</p><p><blockquote>“她写道：”在我们看来，建立在高倍数股票背后的担忧之墙对创新领域的股票来说是个好兆头。“1999 年，担忧之墙并不存在，也没有考验股市。这一次，担忧之墙已经攀升到了极高的高度，”伍德说。</blockquote></p><p> On the macroeconomic front, Wood said that deflation, rather than inflation, could be a bigger problem for markets in the coming months.</p><p><blockquote>在宏观经济方面，伍德表示，未来几个月市场面临的问题可能是通货紧缩而不是通货膨胀。</blockquote></p><p></p><p> “That said, my conviction is growing that the bigger surprise to the markets will be price deflation – both cyclical and secular – and that, after collapsing this year, higher multiple stocks could turn around dramatically during the next year,” she wrote.</p><p><blockquote>“她写道：”尽管如此，我越来越相信，给市场带来更大的惊喜将是价格通缩--包括周期性的和长期性的--而且，在今年崩盘之后，多只股票可能会在明年出现戏剧性的好转。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/cathie-wood-says-stocks-have-corrected-into-deep-value-territory-and-wont-let-benchmarks-hold-our-strategies-hostage-11639795224?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","ARKK":"ARK Innovation ETF","TSLA":"特斯拉","TDOC":"Teladoc Health Inc."},"source_url":"https://www.marketwatch.com/story/cathie-wood-says-stocks-have-corrected-into-deep-value-territory-and-wont-let-benchmarks-hold-our-strategies-hostage-11639795224?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192708619","content_text":"ARK Invest founder Cathie Wood offered the latest defense of the once-highflying, disruptive innovation strategies that had made her suite of exchange-traded funds among the most popular, and best-performing, on Wall Street in 2020.\nPatrick T. Fallon/AFP/Getty Images\nIn a Friday evening blog post, Wood said that despite a brutal stretch that has compelled the operators of the ARK Invest ETFs, including the flagship Ark Innovation fund, to do some soul-searching, the fund manager is sticking to her game plan.\n\n “‘With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years.’”\n\n“We won’t let benchmarks and tracking errors hold our strategies hostage to the existing world order,” Wood wrote. She described the success of the ARK ETFs as one not solely bolstered by fervor for “stay at home” investment opportunities, amid the COVID pandemic, but rooted in identifying paradigm-shifting innovation, from blockchain and bitcoin to electric vehicles.\n“Critical to investment success will be moving to the right side of change, avoiding industries and companies caught in the crosshairs of ‘creative destruction’ and embracing those on the leading edge of ‘disruptive innovation,'” Wood wrote.\nOn Friday, ARK Innovation ended the session up nearly 6% and produced its second straight sharp weekly gain, up 1.1%, following a 1.8% advance in the prior week. The advance for ARK Innovation still leaves the actively managed fund down nearly 22% in the year to date, as the broader S&P 500,the Dow Jones Industrial Average and the technology Nasdaq Composite Index have faced whipsawing volatility derived primarily from concerns about more transmissible strains of COVID, surging inflation and global monetary policy’s reaction to those pricing pressures. Year-to-date the S&P 500 index is up 864.57 points or 23.02%.\nARK’s seven ETFs returned an average of 141% in 2020, on the back of gains from companies such as Tesla Inc.,and Teladoc Health Inc., making Wood the toast of Wall Street. But those funds, focused primarily on companies that aren’t yet profitable, have been limping lower since hitting a peak back in February, and their woeful performance has raised questions about the prospects for the ETFs in the months and years to come.\nWood urged investors to maintain their support of the ARK complex and said that maintaining a long-term, five-year time horizon would be the best way to judge the fund manager’s true performance.\n“With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years,” the ARK CEO wrote.\n“In other words, if our research is correct—and I believe that our research on innovation is the best in the financial world—then our strategies will triple to quintuple in value over the next five years,” Wood added.\nThe ARK founder also made the case that the Nasdaq and S&P 500 could be the bigger disappointment to return-eager investors in the longer-term because they are more overvalued than the disruptive investments that comprise her funds.\n“Unlike many innovation-related stocks, equity benchmarks are selling at record high prices and near record high valuations, 26x for the S&P 500 and 127x for the Nasdaq on a trailing twelve-month basis,” Wood wrote.\nShe said that the “five major innovation platforms which involve 14 technologies are likely to transform the existing world order and that so-called tried and true investment strategies “will disappoint during the next five to ten years as DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain technology scale and converge.”\nWood also made the case that the so-called wall of worry, with inflation fears representing perhaps the biggest concern, provided an ideal backdrop for further advances in innovation stocks in the longer run because the dot-com markets of the late-1990s weren’t properly buffeted by investor concerns. The thinking is that “walls of worry” tend to limit market euphoria.\n“In our view, the wall of worry built on the back of high multiple stocks bodes well for equities in the innovation space,” she wrote. “No wall of worry existed or tested the equity market in 1999. This time around, the wall of worry has scaled to enormous heights,” Wood said.\nOn the macroeconomic front, Wood said that deflation, rather than inflation, could be a bigger problem for markets in the coming months.\n“That said, my conviction is growing that the bigger surprise to the markets will be price deflation – both cyclical and secular – and that, after collapsing this year, higher multiple stocks could turn around dramatically during the next year,” she wrote.","news_type":1,"symbols_score_info":{".DJI":0.9,"TSLA":0.9,".IXIC":0.9,"ARKIU":0.9,"ARKK":0.9,"TDOC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":3401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699387884,"gmtCreate":1639750034660,"gmtModify":1639750034731,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Agree for a change.. adding both DCA","listText":"Agree for a change.. adding both DCA","text":"Agree for a change.. adding both DCA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699387884","repostId":"2192783759","repostType":2,"isVote":1,"tweetType":1,"viewCount":4434,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607555922,"gmtCreate":1639568936763,"gmtModify":1639570838885,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Waiting to enter leaps call around 130 or below","listText":"Waiting to enter leaps call around 130 or below","text":"Waiting to enter leaps call around 130 or below","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607555922","repostId":"1139959073","repostType":4,"isVote":1,"tweetType":1,"viewCount":2850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607550642,"gmtCreate":1639568057454,"gmtModify":1639568057750,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Uff time for me to exit Xpeng.. ARK ETF’s are good candidates of shorting.. this is completely my view","listText":"Uff time for me to exit Xpeng.. ARK ETF’s are good candidates of shorting.. this is completely my view","text":"Uff time for me to exit Xpeng.. ARK ETF’s are good candidates of shorting.. this is completely my view","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607550642","repostId":"1160618167","repostType":2,"repost":{"id":"1160618167","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639551825,"share":"https://www.laohunote.com/m/news/1160618167?lang=zh_CN&edition=full","pubTime":"2021-12-15 15:03","market":"us","language":"en","title":"Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival<blockquote>凯西·伍德 (Cathie Wood) 在这家中国特斯拉竞争对手中又投入了 430 万美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1160618167","media":"Benzinga Earnings","summary":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in t","content":"<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p><p><blockquote>热门投资管理公司<b>方舟投资、</b>领导<b>凯西·伍德，</b>周二，购买了更多在美国上市的中国电动汽车制造商的股票<b>小鹏汽车</b>（纽约证券交易所股票代码：XPEV）下跌。</blockquote></p><p> Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p><p><blockquote>Ark Invest 购买了总部位于中国广州的小鹏汽车 97,697 股股票，估计价值 434 万美元。</blockquote></p><p> Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p><p><blockquote>小鹏汽车股价周二收盘下跌 1.92%，报每股 44.47 美元，过去五天下跌了 7.35%。</blockquote></p><p> Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p><p><blockquote>小鹏汽车和其他中国同行股票，例如<b>蔚来公司</b>（纽约证券交易所股票代码：NIO）最近一直面临压力。</blockquote></p><p> Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p><p><blockquote>小鹏汽车领先于当地竞争对手蔚来和<b>理想汽车公司</b>（纳斯达克股票代码：LI）报告 11 月份交付量时的月度交易量。</blockquote></p><p> Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p><p><blockquote>这三家公司均表示，他们交付了超过 10,000 辆电动汽车，其中小鹏汽车以 15,613 辆位居榜首，理想汽车以 13,485 辆位居第二，蔚来本月向经销商交付了 10,878 辆。</blockquote></p><p> Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p><p><blockquote>小鹏汽车董事长顾布莱恩上个月表示，该公司的目标是在中国境外销售一半的电动汽车。</blockquote></p><p> The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p><p><blockquote>这家电动轿车和SUV制造商已经在挪威销售电动汽车，并计划明年加大海外投资，包括瑞典、丹麦和荷兰。</blockquote></p><p> Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p><p><blockquote>Ark Invest 通过<b>ArkAutonomous 技术与机器人 ETF</b>.</blockquote></p><p> ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p><p><blockquote>在周二的交易之前，ARKQ 持有 524,034 股小鹏汽车股票，价值 2,374 万美元。</blockquote></p><p> <b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p><p><blockquote><b>特斯拉公司</b>是 Ark Invest 大量购买的唯一另一家全电动汽车制造商。该公司将特斯拉视为其最大的控股公司，并通过其交易所交易基金持有该公司价值数十亿美元的股票。</blockquote></p><p> The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p><p><blockquote>自9月初该公司股价开始上涨以来，这家投资公司一直在特斯拉录得利润。</blockquote></p><p> Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p><p><blockquote>特斯拉股价已跌破 1,000 美元水平，其市值目前也低于 1 万亿美元。</blockquote></p><p> Here are a few other key Ark trades from Tuesday:</p><p><blockquote>以下是周二的其他一些重要方舟交易：</blockquote></p><p> <ul>  <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>  <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li> </ul></p><p><blockquote><ul><li>购买了 11,671 股股票，估计价值 300 万美元<b>比特币基地</b> <b>环球公司</b>该股周二收盘上涨1.79%，至每股255.86美元。</li><li>出售 56,925 股股票（估计价值 440 万美元）<b>京东公司</b>该股收盘下跌 0.51%，至每股 77.65 美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival<blockquote>凯西·伍德 (Cathie Wood) 在这家中国特斯拉竞争对手中又投入了 430 万美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival<blockquote>凯西·伍德 (Cathie Wood) 在这家中国特斯拉竞争对手中又投入了 430 万美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-12-15 15:03</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p><p><blockquote>热门投资管理公司<b>方舟投资、</b>领导<b>凯西·伍德，</b>周二，购买了更多在美国上市的中国电动汽车制造商的股票<b>小鹏汽车</b>（纽约证券交易所股票代码：XPEV）下跌。</blockquote></p><p> Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p><p><blockquote>Ark Invest 购买了总部位于中国广州的小鹏汽车 97,697 股股票，估计价值 434 万美元。</blockquote></p><p> Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p><p><blockquote>小鹏汽车股价周二收盘下跌 1.92%，报每股 44.47 美元，过去五天下跌了 7.35%。</blockquote></p><p> Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p><p><blockquote>小鹏汽车和其他中国同行股票，例如<b>蔚来公司</b>（纽约证券交易所股票代码：NIO）最近一直面临压力。</blockquote></p><p> Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p><p><blockquote>小鹏汽车领先于当地竞争对手蔚来和<b>理想汽车公司</b>（纳斯达克股票代码：LI）报告 11 月份交付量时的月度交易量。</blockquote></p><p> Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p><p><blockquote>这三家公司均表示，他们交付了超过 10,000 辆电动汽车，其中小鹏汽车以 15,613 辆位居榜首，理想汽车以 13,485 辆位居第二，蔚来本月向经销商交付了 10,878 辆。</blockquote></p><p> Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p><p><blockquote>小鹏汽车董事长顾布莱恩上个月表示，该公司的目标是在中国境外销售一半的电动汽车。</blockquote></p><p> The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p><p><blockquote>这家电动轿车和SUV制造商已经在挪威销售电动汽车，并计划明年加大海外投资，包括瑞典、丹麦和荷兰。</blockquote></p><p> Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p><p><blockquote>Ark Invest 通过<b>ArkAutonomous 技术与机器人 ETF</b>.</blockquote></p><p> ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p><p><blockquote>在周二的交易之前，ARKQ 持有 524,034 股小鹏汽车股票，价值 2,374 万美元。</blockquote></p><p> <b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p><p><blockquote><b>特斯拉公司</b>是 Ark Invest 大量购买的唯一另一家全电动汽车制造商。该公司将特斯拉视为其最大的控股公司，并通过其交易所交易基金持有该公司价值数十亿美元的股票。</blockquote></p><p> The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p><p><blockquote>自9月初该公司股价开始上涨以来，这家投资公司一直在特斯拉录得利润。</blockquote></p><p> Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p><p><blockquote>特斯拉股价已跌破 1,000 美元水平，其市值目前也低于 1 万亿美元。</blockquote></p><p> Here are a few other key Ark trades from Tuesday:</p><p><blockquote>以下是周二的其他一些重要方舟交易：</blockquote></p><p> <ul>  <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>  <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li> </ul></p><p><blockquote><ul><li>购买了 11,671 股股票，估计价值 300 万美元<b>比特币基地</b> <b>环球公司</b>该股周二收盘上涨1.79%，至每股255.86美元。</li><li>出售 56,925 股股票（估计价值 440 万美元）<b>京东公司</b>该股收盘下跌 0.51%，至每股 77.65 美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏集团","ARKQ":"ARK Autonomous Technology & Robotics ETF","JD":"京东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160618167","content_text":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker Xpeng Inc(NYSE:XPEV) on the dip.\nArk Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.\nXpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.\nXpeng and other Chinese peer shares such as Nio Inc(NYSE:NIO) have been under pressure recently.\nXpeng bolted ahead of local rivals Nio and Li Auto Inc(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.\nEach of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.\nXpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.\nThe maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.\nArk Invest bought shares in Xpeng via the ArkAutonomous Technology & Robotics ETF.\nARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.\nTesla Inc is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.\nThe investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.\nTesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.\nHere are a few other key Ark trades from Tuesday:\n\nBought 11,671 shares — estimated to be worth $3 million — in Coinbase Global Inc. The stock closed 1.79% higher at $255.86 a share on Tuesday.\nSold 56,925 shares — estimated to be worth $4.4 million — inJD.com Inc. The stock closed 0.51% lower at $77.65 a share.","news_type":1,"symbols_score_info":{"ARKQ":0,"JD":0,"XPEV":0}},"isVote":1,"tweetType":1,"viewCount":3109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608507755,"gmtCreate":1638755224231,"gmtModify":1638755224231,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","listText":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","text":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608507755","repostId":"1107533977","repostType":4,"repost":{"id":"1107533977","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638754268,"share":"https://www.laohunote.com/m/news/1107533977?lang=zh_CN&edition=full","pubTime":"2021-12-06 09:31","market":"hk","language":"en","title":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107533977","media":"Tiger Newspress","summary":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.","content":"<p>Li&nbsp;Auto&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;14%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;XPeng&nbsp;fell&nbsp;nearly&nbsp;9%.<img src=\"https://static.tigerbbs.com/f4c63a9e3fe26341f23934616826c6a2\" tg-width=\"747\" tg-height=\"603\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/12cd5c05e050cc41f92f4263ac49921a\" tg-width=\"710\" tg-height=\"606\" width=\"100%\" height=\"auto\"></p><p><blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLi Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 09:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Li&nbsp;Auto&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;14%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;XPeng&nbsp;fell&nbsp;nearly&nbsp;9%.<img src=\"https://static.tigerbbs.com/f4c63a9e3fe26341f23934616826c6a2\" tg-width=\"747\" tg-height=\"603\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/12cd5c05e050cc41f92f4263ac49921a\" tg-width=\"710\" tg-height=\"606\" width=\"100%\" height=\"auto\"></p><p><blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","02015":"理想汽车-W","09868":"小鹏集团-W","XPEV":"小鹏集团"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107533977","content_text":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.","news_type":1,"symbols_score_info":{"LI":0.9,"09868":0.9,"XPEV":0.9,"02015":0.9}},"isVote":1,"tweetType":1,"viewCount":4516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603029630,"gmtCreate":1638342089689,"gmtModify":1638342098661,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Pump and dump cathie ..","listText":"Pump and dump cathie ..","text":"Pump and dump cathie ..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603029630","repostId":"2188553204","repostType":4,"isVote":1,"tweetType":1,"viewCount":2731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873415599,"gmtCreate":1636975301716,"gmtModify":1636975301716,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.&nbsp;","listText":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.&nbsp;","text":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873415599","repostId":"2183046479","repostType":4,"isVote":1,"tweetType":1,"viewCount":4800,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842072401,"gmtCreate":1636122794708,"gmtModify":1636122794836,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"For a change I agree.. Starbucks! but they need to evolve if they want to survive&nbsp;","listText":"For a change I agree.. Starbucks! but they need to evolve if they want to survive&nbsp;","text":"For a change I agree.. Starbucks! but they need to evolve if they want to survive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842072401","repostId":"1156284404","repostType":4,"repost":{"id":"1156284404","kind":"news","pubTimestamp":1636121042,"share":"https://www.laohunote.com/m/news/1156284404?lang=zh_CN&edition=full","pubTime":"2021-11-05 22:04","market":"us","language":"en","title":"Better Buy: Disney vs. Starbucks<blockquote>更好的购买：迪士尼与星巴克</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156284404","media":"Motley Fool ","summary":"Both have strong brands, but one gets the nod.","content":"<p>It is always difficult to choose between two high-quality companies. Ideally, you might like to purchase both. Yet, frequently investing comes down to where to put your hard-earned money.</p><p><blockquote>在两家优质公司之间总是很难做出选择。理想情况下，你可能想两者都买。然而，频繁的投资归结为把你的血汗钱放在哪里。</blockquote></p><p> That's the case with&nbsp;<b>Walt Disney</b>&nbsp;and&nbsp;<b>Starbucks</b>. Both stocks have had a challenging 2021. Disney's share price is down 6%, while Starbucks' stock has dropped by 5%. This comes as the&nbsp;<b>S&amp;P 500</b>&nbsp;has risen by 24% during that time.</p><p><blockquote>情况就是这样<b>华特·迪士尼</b>和<b>星巴克</b>这两只股票都经历了充满挑战的 2021 年。迪士尼股价下跌6%，星巴克股价下跌5%。这就像<b>标普500</b>在此期间上涨了 24%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/92d7cd6a38784299fa1cce99ae01a4cd\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> However, both offer investors solid long-term growth prospects. The question is: Which one is the better investment right now?</p><p><blockquote>然而，两者都为投资者提供了坚实的长期增长前景。问题是：现在哪个是更好的投资？</blockquote></p><p> <b>Starbucks</b></p><p><blockquote><b>星巴克</b></blockquote></p><p> Investors clearly didn't like Starbucks' latest quarterly earnings report. Following the late-October release, they sent the stock down by 6% to about $106. The issue stemmed from&nbsp;higher costs&nbsp;that will likely continue weighing on near-term profitability.</p><p><blockquote>投资者显然不喜欢星巴克最新的季度收益报告。10 月下旬发布后，他们将股价下跌 6%，至约 106 美元。这个问题源于成本上升，这可能会继续影响近期盈利能力。</blockquote></p><p> In the latest quarter, Starbucks' operating margin under&nbsp;U.S. generally accepted accounting principles(GAAP) more than doubled to 18.2%. But for next year, management expects a 17% margin, largely due to higher wages. While this is below its 18% to 19% long-term target, I believe this will prove temporary.</p><p><blockquote>最近一个季度，星巴克在美国的营业利润率公认会计准则 (GAAP) 增长了一倍多，达到 18.2%。但对于明年，管理层预计利润率为 17%，这主要是由于工资上涨。虽然这低于 18% 至 19% 的长期目标，但我相信这将被证明是暂时的。</blockquote></p><p> That's because Starbucks continues to post strong sales growth. That will help the company increase prices and leverage expenses.</p><p><blockquote>这是因为星巴克继续保持强劲的销售增长。这将有助于公司提高价格并杠杆费用。</blockquote></p><p> Starbucks' quarterly revenue rose by 31% to $8.1 billion, driven by new restaurant openings and a 17% increase in same-store sales. For fiscal 2022, management expects a high single-digit percentage increase in comps and to open 2,000 restaurants, mostly outside of the U.S. It anticipates these will lead to revenue of $32.5 billion to $33 billion,</p><p><blockquote>在新餐厅开业和同店销售额增长 17% 的推动下，星巴克季度收入增长 31%，达到 81 亿美元。对于 2022 财年，管理层预计 comps 将实现高个位数百分比增长，并将开设 2,000 家餐厅，其中大部分位于美国境外。预计这些将带来 325 亿至 330 亿美元的收入，</blockquote></p><p> In short, demand for Starbucks' products, which took a pause during the pandemic due to store closures, remains strong.</p><p><blockquote>简而言之，由于门店关闭，对星巴克产品的需求在疫情期间暂停，但仍然强劲。</blockquote></p><p> <b>Walt Disney</b></p><p><blockquote><b>华特·迪士尼</b></blockquote></p><p> Disney's shares have fallen this year due to concerns about&nbsp;slowing growth at Disney+, its streaming service. As it grew by leaps and bounds during the pandemic, I'm not concerned.</p><p><blockquote>由于担心其流媒体服务 Disney+ 增长放缓，迪士尼股价今年下跌。由于它在疫情期间突飞猛进，我并不担心。</blockquote></p><p> After all, Disney+ had 116 million paid subscribers at the start of July 2021, compared to 103.6 million in April. This is also more than double the 57.5 million from a year ago.</p><p><blockquote>毕竟，截至 2021 年 7 月初，Disney+ 拥有 1.16 亿付费用户，而 4 月份为 1.036 亿。这也是一年前5750万的两倍多。</blockquote></p><p> While it may not have the supersonic growth of the past, Disney+ is still adding subscribers at a nice pace. What's more, Disney is far more than a streaming service. Its vast media empire includes parks, movies, several television networks, and retail stores.</p><p><blockquote>虽然它可能没有过去的超音速增长，但Disney+仍在以良好的速度增加订户。更重要的是，迪士尼远不止是一个流媒体服务。其庞大的媒体帝国包括公园、电影、几个电视网和零售店。</blockquote></p><p> This helps the company produce strong results, even if one part of the business slows. For instance, this year saw the return of live sports that helped its ESPN network, and theme parks reopened. Its quarterly revenue grew by 45% to $17 billion year over year.</p><p><blockquote>这有助于公司产生强劲的业绩，即使业务的一部分放缓。例如，今年见证了直播体育的回归，这有助于其ESPN网络，主题公园也重新开放。其季度收入同比增长 45%，达到 170 亿美元。</blockquote></p><p> With popular media properties, such as a stable of Marvel characters and movies, the future looks bright for Disney. That's because it has highly recognized and well-regarded brands that have proven their staying power. Management has strengthened its position, including buying Twenty-First Century Fox a couple of years ago, which added television networks, Marvel characters, and provided a controlling interest in the streaming service Hulu.</p><p><blockquote>凭借受欢迎的媒体资产，如稳定的漫威角色和电影，迪士尼的未来看起来一片光明。这是因为它拥有高度认可和广受好评的品牌，已经证明了它们的持久力。管理层加强了其地位，包括几年前收购了二十一世纪福克斯公司，该公司增加了电视网络、漫威角色，并提供了流媒体服务 Hulu 的控股权。</blockquote></p><p> After examining both companies, both have strong brands that attract a lot of people. For me, the edge goes to Starbucks, since it has increased dividends since 2010, including during the pandemic. It's nice to receive the income, and it's a positive sign that management and the board of directors have confidence in the future.</p><p><blockquote>考察了这两家公司，两家公司都有强大的品牌，吸引了很多人。对我来说，优势属于星巴克，因为它自 2010 年以来增加了股息，包括在疫情期间。很高兴收到收入，这是管理层和董事会对未来充满信心的积极迹象。</blockquote></p><p> Unfortunately, Disney suspended its dividend last year. While that's certainly understandable given the uncertainty created by the pandemic, it does give a leg up to Starbucks, which saw fit to increase payments.</p><p><blockquote>不幸的是，迪士尼去年暂停了股息。虽然考虑到疫情造成的不确定性，这当然是可以理解的，但这确实给了星巴克一个机会，星巴克认为增加付款是合适的。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Buy: Disney vs. Starbucks<blockquote>更好的购买：迪士尼与星巴克</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Buy: Disney vs. Starbucks<blockquote>更好的购买：迪士尼与星巴克</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool </strong><span class=\"h-time small\">2021-11-05 22:04</span>\n</p>\n</h4>\n</header>\n<article>\n<p>It is always difficult to choose between two high-quality companies. Ideally, you might like to purchase both. Yet, frequently investing comes down to where to put your hard-earned money.</p><p><blockquote>在两家优质公司之间总是很难做出选择。理想情况下，你可能想两者都买。然而，频繁的投资归结为把你的血汗钱放在哪里。</blockquote></p><p> That's the case with&nbsp;<b>Walt Disney</b>&nbsp;and&nbsp;<b>Starbucks</b>. Both stocks have had a challenging 2021. Disney's share price is down 6%, while Starbucks' stock has dropped by 5%. This comes as the&nbsp;<b>S&amp;P 500</b>&nbsp;has risen by 24% during that time.</p><p><blockquote>情况就是这样<b>华特·迪士尼</b>和<b>星巴克</b>这两只股票都经历了充满挑战的 2021 年。迪士尼股价下跌6%，星巴克股价下跌5%。这就像<b>标普500</b>在此期间上涨了 24%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/92d7cd6a38784299fa1cce99ae01a4cd\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> However, both offer investors solid long-term growth prospects. The question is: Which one is the better investment right now?</p><p><blockquote>然而，两者都为投资者提供了坚实的长期增长前景。问题是：现在哪个是更好的投资？</blockquote></p><p> <b>Starbucks</b></p><p><blockquote><b>星巴克</b></blockquote></p><p> Investors clearly didn't like Starbucks' latest quarterly earnings report. Following the late-October release, they sent the stock down by 6% to about $106. The issue stemmed from&nbsp;higher costs&nbsp;that will likely continue weighing on near-term profitability.</p><p><blockquote>投资者显然不喜欢星巴克最新的季度收益报告。10 月下旬发布后，他们将股价下跌 6%，至约 106 美元。这个问题源于成本上升，这可能会继续影响近期盈利能力。</blockquote></p><p> In the latest quarter, Starbucks' operating margin under&nbsp;U.S. generally accepted accounting principles(GAAP) more than doubled to 18.2%. But for next year, management expects a 17% margin, largely due to higher wages. While this is below its 18% to 19% long-term target, I believe this will prove temporary.</p><p><blockquote>最近一个季度，星巴克在美国的营业利润率公认会计准则 (GAAP) 增长了一倍多，达到 18.2%。但对于明年，管理层预计利润率为 17%，这主要是由于工资上涨。虽然这低于 18% 至 19% 的长期目标，但我相信这将被证明是暂时的。</blockquote></p><p> That's because Starbucks continues to post strong sales growth. That will help the company increase prices and leverage expenses.</p><p><blockquote>这是因为星巴克继续保持强劲的销售增长。这将有助于公司提高价格并杠杆费用。</blockquote></p><p> Starbucks' quarterly revenue rose by 31% to $8.1 billion, driven by new restaurant openings and a 17% increase in same-store sales. For fiscal 2022, management expects a high single-digit percentage increase in comps and to open 2,000 restaurants, mostly outside of the U.S. It anticipates these will lead to revenue of $32.5 billion to $33 billion,</p><p><blockquote>在新餐厅开业和同店销售额增长 17% 的推动下，星巴克季度收入增长 31%，达到 81 亿美元。对于 2022 财年，管理层预计 comps 将实现高个位数百分比增长，并将开设 2,000 家餐厅，其中大部分位于美国境外。预计这些将带来 325 亿至 330 亿美元的收入，</blockquote></p><p> In short, demand for Starbucks' products, which took a pause during the pandemic due to store closures, remains strong.</p><p><blockquote>简而言之，由于门店关闭，对星巴克产品的需求在疫情期间暂停，但仍然强劲。</blockquote></p><p> <b>Walt Disney</b></p><p><blockquote><b>华特·迪士尼</b></blockquote></p><p> Disney's shares have fallen this year due to concerns about&nbsp;slowing growth at Disney+, its streaming service. As it grew by leaps and bounds during the pandemic, I'm not concerned.</p><p><blockquote>由于担心其流媒体服务 Disney+ 增长放缓，迪士尼股价今年下跌。由于它在疫情期间突飞猛进，我并不担心。</blockquote></p><p> After all, Disney+ had 116 million paid subscribers at the start of July 2021, compared to 103.6 million in April. This is also more than double the 57.5 million from a year ago.</p><p><blockquote>毕竟，截至 2021 年 7 月初，Disney+ 拥有 1.16 亿付费用户，而 4 月份为 1.036 亿。这也是一年前5750万的两倍多。</blockquote></p><p> While it may not have the supersonic growth of the past, Disney+ is still adding subscribers at a nice pace. What's more, Disney is far more than a streaming service. Its vast media empire includes parks, movies, several television networks, and retail stores.</p><p><blockquote>虽然它可能没有过去的超音速增长，但Disney+仍在以良好的速度增加订户。更重要的是，迪士尼远不止是一个流媒体服务。其庞大的媒体帝国包括公园、电影、几个电视网和零售店。</blockquote></p><p> This helps the company produce strong results, even if one part of the business slows. For instance, this year saw the return of live sports that helped its ESPN network, and theme parks reopened. Its quarterly revenue grew by 45% to $17 billion year over year.</p><p><blockquote>这有助于公司产生强劲的业绩，即使业务的一部分放缓。例如，今年见证了直播体育的回归，这有助于其ESPN网络，主题公园也重新开放。其季度收入同比增长 45%，达到 170 亿美元。</blockquote></p><p> With popular media properties, such as a stable of Marvel characters and movies, the future looks bright for Disney. That's because it has highly recognized and well-regarded brands that have proven their staying power. Management has strengthened its position, including buying Twenty-First Century Fox a couple of years ago, which added television networks, Marvel characters, and provided a controlling interest in the streaming service Hulu.</p><p><blockquote>凭借受欢迎的媒体资产，如稳定的漫威角色和电影，迪士尼的未来看起来一片光明。这是因为它拥有高度认可和广受好评的品牌，已经证明了它们的持久力。管理层加强了其地位，包括几年前收购了二十一世纪福克斯公司，该公司增加了电视网络、漫威角色，并提供了流媒体服务 Hulu 的控股权。</blockquote></p><p> After examining both companies, both have strong brands that attract a lot of people. For me, the edge goes to Starbucks, since it has increased dividends since 2010, including during the pandemic. It's nice to receive the income, and it's a positive sign that management and the board of directors have confidence in the future.</p><p><blockquote>考察了这两家公司，两家公司都有强大的品牌，吸引了很多人。对我来说，优势属于星巴克，因为它自 2010 年以来增加了股息，包括在疫情期间。很高兴收到收入，这是管理层和董事会对未来充满信心的积极迹象。</blockquote></p><p> Unfortunately, Disney suspended its dividend last year. While that's certainly understandable given the uncertainty created by the pandemic, it does give a leg up to Starbucks, which saw fit to increase payments.</p><p><blockquote>不幸的是，迪士尼去年暂停了股息。虽然考虑到疫情造成的不确定性，这当然是可以理解的，但这确实给了星巴克一个机会，星巴克认为增加付款是合适的。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/11/05/better-buy-disney-vs-starbucks/\">Motley Fool </a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼","SBUX":"星巴克"},"source_url":"https://www.fool.com/investing/2021/11/05/better-buy-disney-vs-starbucks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156284404","content_text":"It is always difficult to choose between two high-quality companies. Ideally, you might like to purchase both. Yet, frequently investing comes down to where to put your hard-earned money.\nThat's the case with Walt Disney and Starbucks. Both stocks have had a challenging 2021. Disney's share price is down 6%, while Starbucks' stock has dropped by 5%. This comes as the S&P 500 has risen by 24% during that time.\nIMAGE SOURCE: GETTY IMAGES.\nHowever, both offer investors solid long-term growth prospects. The question is: Which one is the better investment right now?\nStarbucks\nInvestors clearly didn't like Starbucks' latest quarterly earnings report. Following the late-October release, they sent the stock down by 6% to about $106. The issue stemmed from higher costs that will likely continue weighing on near-term profitability.\nIn the latest quarter, Starbucks' operating margin under U.S. generally accepted accounting principles(GAAP) more than doubled to 18.2%. But for next year, management expects a 17% margin, largely due to higher wages. While this is below its 18% to 19% long-term target, I believe this will prove temporary.\nThat's because Starbucks continues to post strong sales growth. That will help the company increase prices and leverage expenses.\nStarbucks' quarterly revenue rose by 31% to $8.1 billion, driven by new restaurant openings and a 17% increase in same-store sales. For fiscal 2022, management expects a high single-digit percentage increase in comps and to open 2,000 restaurants, mostly outside of the U.S. It anticipates these will lead to revenue of $32.5 billion to $33 billion,\nIn short, demand for Starbucks' products, which took a pause during the pandemic due to store closures, remains strong.\nWalt Disney\nDisney's shares have fallen this year due to concerns about slowing growth at Disney+, its streaming service. As it grew by leaps and bounds during the pandemic, I'm not concerned.\nAfter all, Disney+ had 116 million paid subscribers at the start of July 2021, compared to 103.6 million in April. This is also more than double the 57.5 million from a year ago.\nWhile it may not have the supersonic growth of the past, Disney+ is still adding subscribers at a nice pace. What's more, Disney is far more than a streaming service. Its vast media empire includes parks, movies, several television networks, and retail stores.\nThis helps the company produce strong results, even if one part of the business slows. For instance, this year saw the return of live sports that helped its ESPN network, and theme parks reopened. Its quarterly revenue grew by 45% to $17 billion year over year.\nWith popular media properties, such as a stable of Marvel characters and movies, the future looks bright for Disney. That's because it has highly recognized and well-regarded brands that have proven their staying power. Management has strengthened its position, including buying Twenty-First Century Fox a couple of years ago, which added television networks, Marvel characters, and provided a controlling interest in the streaming service Hulu.\nAfter examining both companies, both have strong brands that attract a lot of people. For me, the edge goes to Starbucks, since it has increased dividends since 2010, including during the pandemic. It's nice to receive the income, and it's a positive sign that management and the board of directors have confidence in the future.\nUnfortunately, Disney suspended its dividend last year. While that's certainly understandable given the uncertainty created by the pandemic, it does give a leg up to Starbucks, which saw fit to increase payments.","news_type":1,"symbols_score_info":{"DIS":0.9,"SBUX":0.9}},"isVote":1,"tweetType":1,"viewCount":3734,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848990182,"gmtCreate":1635951643936,"gmtModify":1635951644045,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Nio is bear market 🤔","listText":"Nio is bear market 🤔","text":"Nio is bear market 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848990182","repostId":"2180378727","repostType":2,"isVote":1,"tweetType":1,"viewCount":1082,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863837574,"gmtCreate":1632372393698,"gmtModify":1632800833000,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Suggestions on Adobe buy, am ready to add 30%","listText":"Suggestions on Adobe buy, am ready to add 30%","text":"Suggestions on Adobe buy, am ready to add 30%","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/863837574","repostId":"1137784790","repostType":4,"repost":{"id":"1137784790","kind":"news","pubTimestamp":1632369156,"share":"https://www.laohunote.com/m/news/1137784790?lang=zh_CN&edition=full","pubTime":"2021-09-23 11:52","market":"us","language":"en","title":"5 Stocks to Buy in the September Sell-Off<blockquote>9 月份抛售中值得买入的 5 只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1137784790","media":"Motley Fool","summary":"History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.I can't tell you where Adobe,Markel,Take Two Interactive Software,Vertex Pharmaceuticals, and BostonBeerwill trade next week or next month. But I'm confident they will significantly outperform the market o","content":"<p>History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.</p><p><blockquote>历史表明，市场抛售是将优质公司添加到您的投资组合中的绝佳时机。虽然没有人能预测这种情况何时会发生，但大约每两年会发生一次 10% 的下降。这就是为什么如果最近的低迷持续下去，我重点介绍五家值得购买的优质公司。</blockquote></p><p> I&nbsp;can't&nbsp;tell&nbsp;you&nbsp;where&nbsp;<b>Adobe</b>(NASDAQ:ADBE),<b>Markel</b>(NYSE:MKL),<b>Take Two Interactive Software</b>(NASDAQ:TTWO),<b>Vertex Pharmaceuticals</b>(NASDAQ:VRTX), and&nbsp;<b>BostonBeer</b>(NYSE:SAM)will trade next week or next month. But I'm confident they will significantly outperform the market over the next three-plus years. Here's why.</p><p><blockquote>我不能告诉你在哪里<b>土坯</b>（纳斯达克代码：ADBE），<b>马克尔</b>（纽约证券交易所代码：MKL）<b>拿两个交互软件</b>（纳斯达克股票代码：TTWO），<b>顶点制药</b>（纳斯达克股票代码：VRTX），以及<b>波士顿啤酒</b>（纽约证券交易所股票代码：SAM）将于下周或下个月交易。但我相信他们将在未来三年多的时间里大大跑赢市场。原因如下。</blockquote></p><p> <h3>Adobe</h3> At a market capitalization of $300 billion, Adobe is one of the largest software companies in the world. Its applications are the backbone of a lot of the content creative professionals produce. Through the years, it has also given them the ability to manage, measure, and monetize their output. The company breaks its results into three categories.</p><p><blockquote><h3>土坯</h3>Adobe 市值达 3000 亿美元，是世界上最大的软件公司之一。它的应用程序是创意专业人员制作的许多内容的支柱。多年来，它还赋予了他们管理、衡量和货币化产出的能力。该公司将其业绩分为三类。</blockquote></p><p> Digital media encompasses the company's creative cloud offering. It's a subscription service that houses applications for virtually anyone creating or delivering content. The digital experience segment is a cloud platform that helps companies deliver the most engaging customer experiences. It provides everything from marketing management and automation to digital commerce and predictive analytics. Finally, its publishing and advertising division contains legacy products in addition to its advertising cloud offerings.</p><p><blockquote>数字媒体包括该公司的创意云产品。这是一项订阅服务，为几乎任何创建或交付内容的人提供应用程序。数字体验部分是一个云平台，帮助公司提供最具吸引力的客户体验。它提供从营销管理和自动化到数字商务和预测分析的一切。最后，除了广告云产品之外，其出版和广告部门还包含传统产品。</blockquote></p><p> The business has performed amazingly well. Over the past decade, sales and free cash flow have grown 241% and 281%, respectively. Through the first nine months of its fiscal 2021, it posted revenue of $11.7 billion. That was up 24% from the same period last year and 43% over 2019. It carries little debt and its return on invested capital is 33%. That's slightly better than<b>Microsoft</b>.</p><p><blockquote>这项业务表现惊人地好。过去十年，销售额和自由现金流分别增长了 241% 和 281%。在 2021 财年的前 9 个月，该公司公布的收入为 117 亿美元。这比去年同期增长了24%，比2019年增长了43%。它的债务很少，投资资本回报率为33%。这比<b>微软</b>.</blockquote></p><p> CEO Shantanu Narayen sees strength across the business and believes the digital transformation will power the company's financial performance even while it invests in what it calls \"massive market opportunities.\" There is no question the runway is long. That's why I believe any significant sell-off is a gift to investors. Take advantage if you get it andbuy shares of Adobe.</p><p><blockquote>首席执行官 Shantanu Narayen 看到了整个业务的优势，并相信数字化转型将推动公司的财务业绩，即使该公司投资于 it 评级的“巨大市场机会”。毫无疑问，跑道很长。这就是为什么我认为任何重大抛售都是给投资者的礼物。如果你得到了它，就利用它并购买 Adobe 的股票。</blockquote></p><p> <h3>Markel</h3> Markel has been called the \"baby Berkshire\" for its resemblance to&nbsp;<b>Berkshire Hathaway</b>. It is also an insurance company that uses some of its float -- premiums collected on policies that haven't been paid out in claims -- to invest in stocks and buy businesses. It also manages those businesses in a similar way, treating its holding period as forever.</p><p><blockquote><h3>马克尔</h3>马克尔因长得像伯克希尔而被称为“小伯克希尔”<b>伯克希尔哈撒韦公司</b>.它也是一家保险公司，利用其部分浮动资金（对尚未在索赔中支付的保单收取的保费）投资股票和收购企业。它也以类似的方式管理这些业务，将其持有期视为永久。</blockquote></p><p> One big difference is that Markel is only a $16.5 billion company. That gives it more flexibility in what it can buy and offers the potential for decades of steady, market-beating returns for shareholders. Want proof? Would it surprise you to find out Markel's stock has outperformed Berkshire Hathaway since 1990? It has.</p><p><blockquote>一个很大的区别是，Markel 只是一家市值 165 亿美元的公司。这使其在购买商品方面具有更大的灵活性，并为股东提供了数十年稳定、跑赢市场的回报的潜力。想要证据吗？自 1990 年以来，马克尔的股票表现一直优于伯克希尔哈撒韦公司，您会感到惊讶吗？它有。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/263e423c73746672c28109121ec6d687\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\"><span>MKLDATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>MKLDATA by YCharts</span></p></blockquote></p><p> At less than 37 times the size of Warren Buffett's behemoth, Markel still has an almost limitless opportunity to employ the same model. It might not be an exciting technology stock or double your investment over a short time, but it is a proven market-beating company that can add ballast to a portfolio. If you get a chance to add shares during a sell-off, take it.</p><p><blockquote>马克尔的规模不到沃伦·巴菲特庞然大物的 37 倍，但仍然有几乎无限的机会采用相同的模式。它可能不是一只令人兴奋的科技股，也不是在短时间内将您的投资翻倍，但它是一家被证明跑赢市场的公司，可以为投资组合增加压舱物。如果您在抛售期间有机会增持股票，请抓住机会。</blockquote></p><p> <h3>Take Two Interactive</h3> Take Two has one of the most popular video game franchises of all time --<i>Grand Theft Auto</i>. As of last year, the fifth installment in the series --<i>GTA V</i>-- was the third-best-selling video game ever. It trailed only<i>Minecraft</i>and<i>Tetris</i>. Want more proof? It took<i>GTA V</i>three days to reach $1 billion in sales. That's more than five times faster than the closest video game, the best-performing<i>Harry Potter</i>movie, and<i>Avatar</i>. And the company has more in its stable.</p><p><blockquote><h3>拿两个互动</h3>Take Two 拥有有史以来最受欢迎的视频游戏系列之一——<i>侠盗猎车手</i>截至去年，该系列的第五期--<i>侠盗猎车手V</i>-- 是有史以来第三畅销的电子游戏。它只落后了<i>我的世界</i>和<i>俄罗斯方块</i>想要更多证据吗？它需要<i>侠盗猎车手V</i>三天内销售额达到 10 亿美元。这比最接近的、性能最好的电子游戏快五倍多<i>哈利波特</i>电影，以及<i>头像</i>该公司拥有更多稳定的资产。</blockquote></p><p> Another of its popular games -- the<i>NBA2K</i>series -- is also praised for both its polish and commercial success. But what excites me about Take Two is what those games have in common. They both offer an immersive experience in a virtual world where the possibilities seem endless. As talk of a metaverse becomes more mainstream, the company has already proven it can create engaging virtual worlds where users participate in crafting their own experience, as well as the experience of others. It has set the company apart financially.</p><p><blockquote>它的另一款流行游戏——<i>NBA2K</i>系列-也因其波兰和商业上的成功而受到称赞。但是Take Two让我兴奋的是这些游戏有什么共同点。它们都在一个可能性似乎无穷无尽的虚拟世界中提供了身临其境的体验。随着元宇宙的讨论变得更加主流，该公司已经证明它可以创建引人入胜的虚拟世界，用户可以参与打造自己的体验以及他人的体验。它使公司在财务上与众不同。</blockquote></p><p> Since 2012, sales have grown 308%. That compares favorably to<b>Activision Blizzard</b>'s 70% and<b>Electronic Arts</b>' 36%. Of course, those publishers were already more established. Still, it helps highlight why I think Take Two is the game maker to buy in a market sell-off.</p><p><blockquote>自2012年以来，销售额增长了308%。这与<b>动视暴雪</b>70%和<b>电子艺术</b>'36%.当然，那些出版商已经更成熟了。尽管如此，这有助于强调为什么我认为 Take Two 是游戏制造商在市场抛售中购买的原因。</blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b89d7f36b549065b4545a0fa5c997d02\" tg-width=\"720\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>EA REVENUE (ANNUAL)DATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>EA 收入（年度）数据 by YCharts</span></p></blockquote></p><p> <h3>Vertex Pharmaceuticals</h3> Some drugmakers have a portfolio of treatments across many disease areas. Others focus on one type of ailment and work to dominate the space. That's how Vertex has built a market capitalization of $48 billion and annual revenue of $6.7 billion. The company has four approved drugs for cystic fibrosis -- a disease that causes mucus to build up in organs -- and treats roughly half of the 83,000 patients in the U.S., Europe, Australia, and Canada.</p><p><blockquote><h3>顶点制药</h3>一些制药商拥有涵盖许多疾病领域的治疗组合。其他人专注于一种疾病，并努力主导空间。这就是 Vertex 如何建立 480 亿美元的市值和 67 亿美元的年收入。该公司拥有四种获批的治疗囊性纤维化（一种导致粘液在器官中积聚的疾病）的药物，治疗了美国、欧洲、澳大利亚和加拿大 83,000 名患者中的大约一半。</blockquote></p><p> Management believes it can treat an additional 30,000 of those patients by successfully commercializing drugs in markets where it recently gained approval, obtaining approval in new markets, and rolling out its newest CF drug in the U.S. and Europe.</p><p><blockquote>管理层相信，通过在最近获得批准的市场成功将药物商业化，在新市场获得批准，并在美国和欧洲推出其最新的 CF 药物，该公司可以治疗另外 30,000 名患者。</blockquote></p><p> It has also partnered with other biotechs to maintain its position in CF and explore new growth opportunities. It spent $900 million to purchase a controlling interest in CTX001 -- its collaboration with<b>CRISPR Therapeutics</b>-- for treating sickle cell disease and beta thalassemia. The company also has a non-opioid pain treatment, a drug targeting kidney disease, and a stem cell-derived therapy for type 1 diabetes in clinical trials. Vertex also has pre-clinical gene-based programs with<b>Moderna</b>and Arbor Biotechnologies. It's a robust pipeline with a lot of potential.</p><p><blockquote>它还与其他生物技术公司合作，以保持其在CF的地位并探索新的增长机会。它斥资 9 亿美元购买了 CTX001 的控股权——它与<b>CRISPR 疗法</b>--用于治疗镰状细胞病和β地中海贫血。该公司还有一种非阿片类疼痛治疗药物、一种针对肾脏疾病的药物以及一种治疗 1 型糖尿病的干细胞衍生疗法正在进行临床试验。Vertex 还拥有基于基因的临床前项目<b>现代</b>和阿伯生物技术公司。这是一个强大的管道，具有很大的潜力。</blockquote></p><p> Despite that, Wall Street isn't giving the company a lot of credit. Itsprice-to-sales ratiois the lowest it has been since 2012 -- the year it began selling its first CF drug. Analysts expect sales to climb this year and next, making the discount even more pronounced. With a strong foundation in CF and so much potential in the pipeline, Vertex Pharmaceuticals might already be a steal.</p><p><blockquote>尽管如此，华尔街并没有给予该公司太多信任。其市销率是自 2012 年（该公司开始销售首款 CF 药物的那一年）以来的最低水平。分析师预计今明两年的销售额将会攀升，这使得折扣更加明显。凭借在 CF 领域的坚实基础和巨大的潜力，Vertex Pharmaceuticals 可能已经很便宜了。</blockquote></p><p> <h3>Boston Beer</h3> Riding the trends in the alcoholic beverage industry is like being on a rollercoaster. Tastes in the U.S. have shifted over the years with wine, whiskey, hard cider, craft beers, and hard seltzer each taking a turn as the drink of choice. For the most part, Boston Beer has been able to succeed no matter what was in vogue. But it's been an up and down journey for shareholders. The stock has experienced drops of at least 60% three times in the last 20 years.</p><p><blockquote><h3>波士顿啤酒</h3>驾驭酒精饮料行业的趋势就像乘坐过山车。多年来，美国人的口味发生了变化，葡萄酒、威士忌、烈性苹果酒、精酿啤酒和烈性苏打水轮流成为首选饮料。在很大程度上，无论流行什么，波士顿啤酒都能够成功。但对于股东来说，这是一个跌宕起伏的旅程。该股在过去 20 年中曾三次下跌至少 60%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f60342c3cab8471f9e4dbd370f401b1\" tg-width=\"720\" tg-height=\"433\" referrerpolicy=\"no-referrer\"><span>SAMDATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>SAMDATA by YCharts</span></p></blockquote></p><p> It's in one of those slumps now as Truly -- its hard seltzer brand -- underperforms amid an avalanche of competition. After the decline, the stock is offering investors an opportunity they don't get very often. Analysts still expect revenue of $2.16 billion this year. That makes the projected P/S ratio of less than three close to the lowest level since the beginning of 2019.</p><p><blockquote>它现在正处于低迷状态，因为它的硬苏打水品牌 Truly 在激烈的竞争中表现不佳。下跌之后，该股为投资者提供了一个他们不常获得的机会。分析师仍预计今年营收为 21.6 亿美元。这使得不到三的预计市盈率接近2019年初以来的最低水平。</blockquote></p><p> Of course, it could get worse before it gets better. Management slashed its earnings forecast in July and then pulled guidance earlier this month, saying it would incur write-offs and fees associated with the product. As scary as that is, I'm betting Boston Beer will repeat its history of surviving a downturn, finding a new trend, and powering to new all-time highs in the years ahead.</p><p><blockquote>当然，在好转之前，情况可能会变得更糟。管理层在 7 月份下调了盈利预测，然后在本月早些时候撤回了指引，称这将导致与该产品相关的冲销和费用。尽管这很可怕，但我敢打赌，波士顿啤酒将在未来几年重演其经历低迷、找到新趋势并创下历史新高的历史。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks to Buy in the September Sell-Off<blockquote>9 月份抛售中值得买入的 5 只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks to Buy in the September Sell-Off<blockquote>9 月份抛售中值得买入的 5 只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-09-23 11:52</span>\n</p>\n</h4>\n</header>\n<article>\n<p>History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.</p><p><blockquote>历史表明，市场抛售是将优质公司添加到您的投资组合中的绝佳时机。虽然没有人能预测这种情况何时会发生，但大约每两年会发生一次 10% 的下降。这就是为什么如果最近的低迷持续下去，我重点介绍五家值得购买的优质公司。</blockquote></p><p> I&nbsp;can't&nbsp;tell&nbsp;you&nbsp;where&nbsp;<b>Adobe</b>(NASDAQ:ADBE),<b>Markel</b>(NYSE:MKL),<b>Take Two Interactive Software</b>(NASDAQ:TTWO),<b>Vertex Pharmaceuticals</b>(NASDAQ:VRTX), and&nbsp;<b>BostonBeer</b>(NYSE:SAM)will trade next week or next month. But I'm confident they will significantly outperform the market over the next three-plus years. Here's why.</p><p><blockquote>我不能告诉你在哪里<b>土坯</b>（纳斯达克代码：ADBE），<b>马克尔</b>（纽约证券交易所代码：MKL）<b>拿两个交互软件</b>（纳斯达克股票代码：TTWO），<b>顶点制药</b>（纳斯达克股票代码：VRTX），以及<b>波士顿啤酒</b>（纽约证券交易所股票代码：SAM）将于下周或下个月交易。但我相信他们将在未来三年多的时间里大大跑赢市场。原因如下。</blockquote></p><p> <h3>Adobe</h3> At a market capitalization of $300 billion, Adobe is one of the largest software companies in the world. Its applications are the backbone of a lot of the content creative professionals produce. Through the years, it has also given them the ability to manage, measure, and monetize their output. The company breaks its results into three categories.</p><p><blockquote><h3>土坯</h3>Adobe 市值达 3000 亿美元，是世界上最大的软件公司之一。它的应用程序是创意专业人员制作的许多内容的支柱。多年来，它还赋予了他们管理、衡量和货币化产出的能力。该公司将其业绩分为三类。</blockquote></p><p> Digital media encompasses the company's creative cloud offering. It's a subscription service that houses applications for virtually anyone creating or delivering content. The digital experience segment is a cloud platform that helps companies deliver the most engaging customer experiences. It provides everything from marketing management and automation to digital commerce and predictive analytics. Finally, its publishing and advertising division contains legacy products in addition to its advertising cloud offerings.</p><p><blockquote>数字媒体包括该公司的创意云产品。这是一项订阅服务，为几乎任何创建或交付内容的人提供应用程序。数字体验部分是一个云平台，帮助公司提供最具吸引力的客户体验。它提供从营销管理和自动化到数字商务和预测分析的一切。最后，除了广告云产品之外，其出版和广告部门还包含传统产品。</blockquote></p><p> The business has performed amazingly well. Over the past decade, sales and free cash flow have grown 241% and 281%, respectively. Through the first nine months of its fiscal 2021, it posted revenue of $11.7 billion. That was up 24% from the same period last year and 43% over 2019. It carries little debt and its return on invested capital is 33%. That's slightly better than<b>Microsoft</b>.</p><p><blockquote>这项业务表现惊人地好。过去十年，销售额和自由现金流分别增长了 241% 和 281%。在 2021 财年的前 9 个月，该公司公布的收入为 117 亿美元。这比去年同期增长了24%，比2019年增长了43%。它的债务很少，投资资本回报率为33%。这比<b>微软</b>.</blockquote></p><p> CEO Shantanu Narayen sees strength across the business and believes the digital transformation will power the company's financial performance even while it invests in what it calls \"massive market opportunities.\" There is no question the runway is long. That's why I believe any significant sell-off is a gift to investors. Take advantage if you get it andbuy shares of Adobe.</p><p><blockquote>首席执行官 Shantanu Narayen 看到了整个业务的优势，并相信数字化转型将推动公司的财务业绩，即使该公司投资于 it 评级的“巨大市场机会”。毫无疑问，跑道很长。这就是为什么我认为任何重大抛售都是给投资者的礼物。如果你得到了它，就利用它并购买 Adobe 的股票。</blockquote></p><p> <h3>Markel</h3> Markel has been called the \"baby Berkshire\" for its resemblance to&nbsp;<b>Berkshire Hathaway</b>. It is also an insurance company that uses some of its float -- premiums collected on policies that haven't been paid out in claims -- to invest in stocks and buy businesses. It also manages those businesses in a similar way, treating its holding period as forever.</p><p><blockquote><h3>马克尔</h3>马克尔因长得像伯克希尔而被称为“小伯克希尔”<b>伯克希尔哈撒韦公司</b>.它也是一家保险公司，利用其部分浮动资金（对尚未在索赔中支付的保单收取的保费）投资股票和收购企业。它也以类似的方式管理这些业务，将其持有期视为永久。</blockquote></p><p> One big difference is that Markel is only a $16.5 billion company. That gives it more flexibility in what it can buy and offers the potential for decades of steady, market-beating returns for shareholders. Want proof? Would it surprise you to find out Markel's stock has outperformed Berkshire Hathaway since 1990? It has.</p><p><blockquote>一个很大的区别是，Markel 只是一家市值 165 亿美元的公司。这使其在购买商品方面具有更大的灵活性，并为股东提供了数十年稳定、跑赢市场的回报的潜力。想要证据吗？自 1990 年以来，马克尔的股票表现一直优于伯克希尔哈撒韦公司，您会感到惊讶吗？它有。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/263e423c73746672c28109121ec6d687\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\"><span>MKLDATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>MKLDATA by YCharts</span></p></blockquote></p><p> At less than 37 times the size of Warren Buffett's behemoth, Markel still has an almost limitless opportunity to employ the same model. It might not be an exciting technology stock or double your investment over a short time, but it is a proven market-beating company that can add ballast to a portfolio. If you get a chance to add shares during a sell-off, take it.</p><p><blockquote>马克尔的规模不到沃伦·巴菲特庞然大物的 37 倍，但仍然有几乎无限的机会采用相同的模式。它可能不是一只令人兴奋的科技股，也不是在短时间内将您的投资翻倍，但它是一家被证明跑赢市场的公司，可以为投资组合增加压舱物。如果您在抛售期间有机会增持股票，请抓住机会。</blockquote></p><p> <h3>Take Two Interactive</h3> Take Two has one of the most popular video game franchises of all time --<i>Grand Theft Auto</i>. As of last year, the fifth installment in the series --<i>GTA V</i>-- was the third-best-selling video game ever. It trailed only<i>Minecraft</i>and<i>Tetris</i>. Want more proof? It took<i>GTA V</i>three days to reach $1 billion in sales. That's more than five times faster than the closest video game, the best-performing<i>Harry Potter</i>movie, and<i>Avatar</i>. And the company has more in its stable.</p><p><blockquote><h3>拿两个互动</h3>Take Two 拥有有史以来最受欢迎的视频游戏系列之一——<i>侠盗猎车手</i>截至去年，该系列的第五期--<i>侠盗猎车手V</i>-- 是有史以来第三畅销的电子游戏。它只落后了<i>我的世界</i>和<i>俄罗斯方块</i>想要更多证据吗？它需要<i>侠盗猎车手V</i>三天内销售额达到 10 亿美元。这比最接近的、性能最好的电子游戏快五倍多<i>哈利波特</i>电影，以及<i>头像</i>该公司拥有更多稳定的资产。</blockquote></p><p> Another of its popular games -- the<i>NBA2K</i>series -- is also praised for both its polish and commercial success. But what excites me about Take Two is what those games have in common. They both offer an immersive experience in a virtual world where the possibilities seem endless. As talk of a metaverse becomes more mainstream, the company has already proven it can create engaging virtual worlds where users participate in crafting their own experience, as well as the experience of others. It has set the company apart financially.</p><p><blockquote>它的另一款流行游戏——<i>NBA2K</i>系列-也因其波兰和商业上的成功而受到称赞。但是Take Two让我兴奋的是这些游戏有什么共同点。它们都在一个可能性似乎无穷无尽的虚拟世界中提供了身临其境的体验。随着元宇宙的讨论变得更加主流，该公司已经证明它可以创建引人入胜的虚拟世界，用户可以参与打造自己的体验以及他人的体验。它使公司在财务上与众不同。</blockquote></p><p> Since 2012, sales have grown 308%. That compares favorably to<b>Activision Blizzard</b>'s 70% and<b>Electronic Arts</b>' 36%. Of course, those publishers were already more established. Still, it helps highlight why I think Take Two is the game maker to buy in a market sell-off.</p><p><blockquote>自2012年以来，销售额增长了308%。这与<b>动视暴雪</b>70%和<b>电子艺术</b>'36%.当然，那些出版商已经更成熟了。尽管如此，这有助于强调为什么我认为 Take Two 是游戏制造商在市场抛售中购买的原因。</blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b89d7f36b549065b4545a0fa5c997d02\" tg-width=\"720\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>EA REVENUE (ANNUAL)DATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>EA 收入（年度）数据 by YCharts</span></p></blockquote></p><p> <h3>Vertex Pharmaceuticals</h3> Some drugmakers have a portfolio of treatments across many disease areas. Others focus on one type of ailment and work to dominate the space. That's how Vertex has built a market capitalization of $48 billion and annual revenue of $6.7 billion. The company has four approved drugs for cystic fibrosis -- a disease that causes mucus to build up in organs -- and treats roughly half of the 83,000 patients in the U.S., Europe, Australia, and Canada.</p><p><blockquote><h3>顶点制药</h3>一些制药商拥有涵盖许多疾病领域的治疗组合。其他人专注于一种疾病，并努力主导空间。这就是 Vertex 如何建立 480 亿美元的市值和 67 亿美元的年收入。该公司拥有四种获批的治疗囊性纤维化（一种导致粘液在器官中积聚的疾病）的药物，治疗了美国、欧洲、澳大利亚和加拿大 83,000 名患者中的大约一半。</blockquote></p><p> Management believes it can treat an additional 30,000 of those patients by successfully commercializing drugs in markets where it recently gained approval, obtaining approval in new markets, and rolling out its newest CF drug in the U.S. and Europe.</p><p><blockquote>管理层相信，通过在最近获得批准的市场成功将药物商业化，在新市场获得批准，并在美国和欧洲推出其最新的 CF 药物，该公司可以治疗另外 30,000 名患者。</blockquote></p><p> It has also partnered with other biotechs to maintain its position in CF and explore new growth opportunities. It spent $900 million to purchase a controlling interest in CTX001 -- its collaboration with<b>CRISPR Therapeutics</b>-- for treating sickle cell disease and beta thalassemia. The company also has a non-opioid pain treatment, a drug targeting kidney disease, and a stem cell-derived therapy for type 1 diabetes in clinical trials. Vertex also has pre-clinical gene-based programs with<b>Moderna</b>and Arbor Biotechnologies. It's a robust pipeline with a lot of potential.</p><p><blockquote>它还与其他生物技术公司合作，以保持其在CF的地位并探索新的增长机会。它斥资 9 亿美元购买了 CTX001 的控股权——它与<b>CRISPR 疗法</b>--用于治疗镰状细胞病和β地中海贫血。该公司还有一种非阿片类疼痛治疗药物、一种针对肾脏疾病的药物以及一种治疗 1 型糖尿病的干细胞衍生疗法正在进行临床试验。Vertex 还拥有基于基因的临床前项目<b>现代</b>和阿伯生物技术公司。这是一个强大的管道，具有很大的潜力。</blockquote></p><p> Despite that, Wall Street isn't giving the company a lot of credit. Itsprice-to-sales ratiois the lowest it has been since 2012 -- the year it began selling its first CF drug. Analysts expect sales to climb this year and next, making the discount even more pronounced. With a strong foundation in CF and so much potential in the pipeline, Vertex Pharmaceuticals might already be a steal.</p><p><blockquote>尽管如此，华尔街并没有给予该公司太多信任。其市销率是自 2012 年（该公司开始销售首款 CF 药物的那一年）以来的最低水平。分析师预计今明两年的销售额将会攀升，这使得折扣更加明显。凭借在 CF 领域的坚实基础和巨大的潜力，Vertex Pharmaceuticals 可能已经很便宜了。</blockquote></p><p> <h3>Boston Beer</h3> Riding the trends in the alcoholic beverage industry is like being on a rollercoaster. Tastes in the U.S. have shifted over the years with wine, whiskey, hard cider, craft beers, and hard seltzer each taking a turn as the drink of choice. For the most part, Boston Beer has been able to succeed no matter what was in vogue. But it's been an up and down journey for shareholders. The stock has experienced drops of at least 60% three times in the last 20 years.</p><p><blockquote><h3>波士顿啤酒</h3>驾驭酒精饮料行业的趋势就像乘坐过山车。多年来，美国人的口味发生了变化，葡萄酒、威士忌、烈性苹果酒、精酿啤酒和烈性苏打水轮流成为首选饮料。在很大程度上，无论流行什么，波士顿啤酒都能够成功。但对于股东来说，这是一个跌宕起伏的旅程。该股在过去 20 年中曾三次下跌至少 60%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f60342c3cab8471f9e4dbd370f401b1\" tg-width=\"720\" tg-height=\"433\" referrerpolicy=\"no-referrer\"><span>SAMDATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>SAMDATA by YCharts</span></p></blockquote></p><p> It's in one of those slumps now as Truly -- its hard seltzer brand -- underperforms amid an avalanche of competition. After the decline, the stock is offering investors an opportunity they don't get very often. Analysts still expect revenue of $2.16 billion this year. That makes the projected P/S ratio of less than three close to the lowest level since the beginning of 2019.</p><p><blockquote>它现在正处于低迷状态，因为它的硬苏打水品牌 Truly 在激烈的竞争中表现不佳。下跌之后，该股为投资者提供了一个他们不常获得的机会。分析师仍预计今年营收为 21.6 亿美元。这使得不到三的预计市盈率接近2019年初以来的最低水平。</blockquote></p><p> Of course, it could get worse before it gets better. Management slashed its earnings forecast in July and then pulled guidance earlier this month, saying it would incur write-offs and fees associated with the product. As scary as that is, I'm betting Boston Beer will repeat its history of surviving a downturn, finding a new trend, and powering to new all-time highs in the years ahead.</p><p><blockquote>当然，在好转之前，情况可能会变得更糟。管理层在 7 月份下调了盈利预测，然后在本月早些时候撤回了指引，称这将导致与该产品相关的冲销和费用。尽管这很可怕，但我敢打赌，波士顿啤酒将在未来几年重演其经历低迷、找到新趋势并创下历史新高的历史。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/09/22/5-stocks-to-buy-in-the-september-sell-off/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADBE":"Adobe","MKL":"Markel Corp","TTWO":"Take-Two Interactive Software","SAM":"波斯顿啤酒","VRTX":"福泰制药"},"source_url":"https://www.fool.com/investing/2021/09/22/5-stocks-to-buy-in-the-september-sell-off/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137784790","content_text":"History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.\nI can't tell you where Adobe(NASDAQ:ADBE),Markel(NYSE:MKL),Take Two Interactive Software(NASDAQ:TTWO),Vertex Pharmaceuticals(NASDAQ:VRTX), and BostonBeer(NYSE:SAM)will trade next week or next month. But I'm confident they will significantly outperform the market over the next three-plus years. Here's why.\nAdobe\nAt a market capitalization of $300 billion, Adobe is one of the largest software companies in the world. Its applications are the backbone of a lot of the content creative professionals produce. Through the years, it has also given them the ability to manage, measure, and monetize their output. The company breaks its results into three categories.\nDigital media encompasses the company's creative cloud offering. It's a subscription service that houses applications for virtually anyone creating or delivering content. The digital experience segment is a cloud platform that helps companies deliver the most engaging customer experiences. It provides everything from marketing management and automation to digital commerce and predictive analytics. Finally, its publishing and advertising division contains legacy products in addition to its advertising cloud offerings.\nThe business has performed amazingly well. Over the past decade, sales and free cash flow have grown 241% and 281%, respectively. Through the first nine months of its fiscal 2021, it posted revenue of $11.7 billion. That was up 24% from the same period last year and 43% over 2019. It carries little debt and its return on invested capital is 33%. That's slightly better thanMicrosoft.\nCEO Shantanu Narayen sees strength across the business and believes the digital transformation will power the company's financial performance even while it invests in what it calls \"massive market opportunities.\" There is no question the runway is long. That's why I believe any significant sell-off is a gift to investors. Take advantage if you get it andbuy shares of Adobe.\nMarkel\nMarkel has been called the \"baby Berkshire\" for its resemblance to Berkshire Hathaway. It is also an insurance company that uses some of its float -- premiums collected on policies that haven't been paid out in claims -- to invest in stocks and buy businesses. It also manages those businesses in a similar way, treating its holding period as forever.\nOne big difference is that Markel is only a $16.5 billion company. That gives it more flexibility in what it can buy and offers the potential for decades of steady, market-beating returns for shareholders. Want proof? Would it surprise you to find out Markel's stock has outperformed Berkshire Hathaway since 1990? It has.\nMKLDATA BYYCHARTS\nAt less than 37 times the size of Warren Buffett's behemoth, Markel still has an almost limitless opportunity to employ the same model. It might not be an exciting technology stock or double your investment over a short time, but it is a proven market-beating company that can add ballast to a portfolio. If you get a chance to add shares during a sell-off, take it.\nTake Two Interactive\nTake Two has one of the most popular video game franchises of all time --Grand Theft Auto. As of last year, the fifth installment in the series --GTA V-- was the third-best-selling video game ever. It trailed onlyMinecraftandTetris. Want more proof? It tookGTA Vthree days to reach $1 billion in sales. That's more than five times faster than the closest video game, the best-performingHarry Pottermovie, andAvatar. And the company has more in its stable.\nAnother of its popular games -- theNBA2Kseries -- is also praised for both its polish and commercial success. But what excites me about Take Two is what those games have in common. They both offer an immersive experience in a virtual world where the possibilities seem endless. As talk of a metaverse becomes more mainstream, the company has already proven it can create engaging virtual worlds where users participate in crafting their own experience, as well as the experience of others. It has set the company apart financially.\nSince 2012, sales have grown 308%. That compares favorably toActivision Blizzard's 70% andElectronic Arts' 36%. Of course, those publishers were already more established. Still, it helps highlight why I think Take Two is the game maker to buy in a market sell-off.\nEA REVENUE (ANNUAL)DATA BYYCHARTS\nVertex Pharmaceuticals\nSome drugmakers have a portfolio of treatments across many disease areas. Others focus on one type of ailment and work to dominate the space. That's how Vertex has built a market capitalization of $48 billion and annual revenue of $6.7 billion. The company has four approved drugs for cystic fibrosis -- a disease that causes mucus to build up in organs -- and treats roughly half of the 83,000 patients in the U.S., Europe, Australia, and Canada.\nManagement believes it can treat an additional 30,000 of those patients by successfully commercializing drugs in markets where it recently gained approval, obtaining approval in new markets, and rolling out its newest CF drug in the U.S. and Europe.\nIt has also partnered with other biotechs to maintain its position in CF and explore new growth opportunities. It spent $900 million to purchase a controlling interest in CTX001 -- its collaboration withCRISPR Therapeutics-- for treating sickle cell disease and beta thalassemia. The company also has a non-opioid pain treatment, a drug targeting kidney disease, and a stem cell-derived therapy for type 1 diabetes in clinical trials. Vertex also has pre-clinical gene-based programs withModernaand Arbor Biotechnologies. It's a robust pipeline with a lot of potential.\nDespite that, Wall Street isn't giving the company a lot of credit. Itsprice-to-sales ratiois the lowest it has been since 2012 -- the year it began selling its first CF drug. Analysts expect sales to climb this year and next, making the discount even more pronounced. With a strong foundation in CF and so much potential in the pipeline, Vertex Pharmaceuticals might already be a steal.\nBoston Beer\nRiding the trends in the alcoholic beverage industry is like being on a rollercoaster. Tastes in the U.S. have shifted over the years with wine, whiskey, hard cider, craft beers, and hard seltzer each taking a turn as the drink of choice. For the most part, Boston Beer has been able to succeed no matter what was in vogue. But it's been an up and down journey for shareholders. The stock has experienced drops of at least 60% three times in the last 20 years.\nSAMDATA BYYCHARTS\nIt's in one of those slumps now as Truly -- its hard seltzer brand -- underperforms amid an avalanche of competition. After the decline, the stock is offering investors an opportunity they don't get very often. Analysts still expect revenue of $2.16 billion this year. That makes the projected P/S ratio of less than three close to the lowest level since the beginning of 2019.\nOf course, it could get worse before it gets better. Management slashed its earnings forecast in July and then pulled guidance earlier this month, saying it would incur write-offs and fees associated with the product. As scary as that is, I'm betting Boston Beer will repeat its history of surviving a downturn, finding a new trend, and powering to new all-time highs in the years ahead.","news_type":1,"symbols_score_info":{"MKL":0.9,"ADBE":0.9,"VRTX":0.9,"TTWO":0.9,"SAM":0.9}},"isVote":1,"tweetType":1,"viewCount":757,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886543377,"gmtCreate":1631608948599,"gmtModify":1631888993340,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"I was thinking about forgerock considering the valuations, any suggestions on investments","listText":"I was thinking about forgerock considering the valuations, any suggestions on investments","text":"I was thinking about forgerock considering the valuations, any suggestions on investments","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/886543377","repostId":"1160275332","repostType":4,"repost":{"id":"1160275332","kind":"news","pubTimestamp":1631604098,"share":"https://www.laohunote.com/m/news/1160275332?lang=zh_CN&edition=full","pubTime":"2021-09-14 15:21","market":"us","language":"en","title":"Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的 IPO 市场有望使 2021 年成为有史以来收益最大的一年</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1160275332","media":"MarketWatch","summary":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit th","content":"<p>Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week </p><p><blockquote>由罗杰·费德勒和得来速咖啡连锁店支持的瑞士跑鞋公司预计将于本周上市</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/18111af5f5bda21b3128860fe616c5ca\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Swiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.</span></p><p><blockquote><p class=\"t-img-caption\"><span>瑞士网球巨人罗杰·费德勒是本周最大的IPO之一的支持者。</span></p></blockquote></p><p> After a flurry of initial-public-offering launches last week&nbsp;set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. </p><p><blockquote>在上周一系列首次公开募股启动让市场陷入繁忙的交易量下跌之后，预计本周将有 11 家公司定价并筹集超过 30 亿美元的收益。</blockquote></p><p> If all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. </p><p><blockquote>机构研究和交易所交易基金提供商 Renaissance Capital 的创始人兼首席执行官比尔·史密斯 (Bill Smith) 表示，如果所有交易都能实现，2021 年将成为有史以来 IPO 收益最大的一年，并打破之前的记录约 30%。据 Renaissance 称，今年市场预计将达成约 375 笔交易，筹集 1250 亿美元，超过 2000 年互联网繁荣时期筹集的 970 亿美元。</blockquote></p><p> “After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. </p><p><blockquote>“史密斯在一篇市场评论中写道：”在漫长的暑假之后，本周是即将到来的科技、生物技术和消费品 IPO 的试金石。这份名单包括一家由网球巨头罗杰·费德勒支持的瑞士跑鞋公司、一家免下车咖啡亭运营商以及一家从保险公司 Genworth Financial 分拆出来的抵押贷款保险公司。</blockquote></p><p> The biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.</p><p><blockquote>本周最大的交易预计将来自总部位于芝加哥的技术咨询公司 Thoughtworks，该公司将以高达 61 亿美元的估值上市。</blockquote></p><p> The company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.</p><p><blockquote>该公司预计在 IPO 完成后将名称从 Turing Holding Corp. 更名为 Thoughtworks，并表示将发行总计 3684 万股股票，分配给公司和出售股东。</blockquote></p><p> The deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.</p><p><blockquote>预计交易价格将在每股 18 美元至 20 美元之间，股票将在纳斯达克交易，股票代码为 “TWKS”。高盛和摩根大通是主承销商。该公司 2020 年收入为 8.034 亿美元，净利润为 7930 万美元，而 2019 年收入为 7.722 亿美元，净利润为 2840 万美元。</blockquote></p><p> The Swiss athletic-footwear maker On Holding&nbsp;is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”</p><p><blockquote>这家持股的瑞士运动鞋制造商预计将以近 60 亿美元的估值筹集高达 6.22 亿美元的资金。On 已申请在纽约证券交易所上市 3110 万股股票，每股定价为 18 至 20 美元，股票代码为 “ONON”。</blockquote></p><p> Goldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.</p><p><blockquote>高盛、摩根士丹利和摩根士丹利是这笔交易的九家银行组成的银团的主承销商。所得款项将用于一般公司用途。该公司有一条与费德勒共同开发的产品线。</blockquote></p><p> The company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period,&nbsp;according to its IPO documents.&nbsp;Sales came to 315.5 million francs, up from 170.9 million francs.</p><p><blockquote>根据其首次公开募股文件，该公司在截至 6 月 30 日的六个月中净利润为 380 万瑞士法郎（约合 410 万美元），而去年同期亏损 3310 万法郎。销售额从 1.709 亿法郎增至 3.155 亿法郎。</blockquote></p><p> Also from Switzerland, sports betting site Sportrader Group AG&nbsp;plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.</p><p><blockquote>同样来自瑞士的体育博彩网站Sportrader Group AG计划发行1900万股股票，每股定价25至28美元，估值高达310亿美元。该公司已申请在纳斯达克上市，股票代码为 “SRAD”。摩根大通、摩根士丹利、花旗集团和瑞银是参与该交易的 13 家银行财团的主承销商。</blockquote></p><p> Proceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million,&nbsp;according to its filing documents.</p><p><blockquote>所得款项将用作营运资金和刺激增长。根据其备案文件，该公司今年前六个月净利润为 2990 万美元，收入为 3.21 亿美元。</blockquote></p><p> Dutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.</p><p><blockquote>Dutch Bros Inc. 是一家主要在美国西部各州提供冷热饮料的免下车商店运营商，计划在 IPO 中发行 2110 万股股票，每股定价为 18 至 20 美元，公司估值高达 33 亿美元。</blockquote></p><p> BofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”</p><p><blockquote>美国银行证券、摩根大通和杰富瑞是参与该交易的 13 家银行财团的主承销商。该公司已申请在纽约证券交易所上市，股票代码为 “BROS.</blockquote></p><p> Proceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.</p><p><blockquote>所得款项将用于购买额外的 A 类股票——该公司计划持有四类具有不同投票权的股票。该公司今年前六个月净亏损 1,360 万美元，即每股亏损 32 美分，低于去年同期公布的 1,650 万美元，即每股亏损 38 美分。收入从 3.274 亿美元降至 2.279 亿美元。</blockquote></p><p> <b>Rounding out the list are:</b></p><p><blockquote><b>最后一个列表是：</b></blockquote></p><p> •&nbsp;Definitive Healthcare Corp.,&nbsp;a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.</p><p><blockquote>- 总部位于马萨诸塞州的医疗保健商业智能提供商 Definitive Healthcare Corp. 计划在其 PO 中发行 1556 万股股票，预计每股价格在 21 至 24 美元之间。按照这个定价，该公司的估值可能高达 35.5 亿美元。</blockquote></p><p></p><p> •&nbsp;Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.</p><p><blockquote>- Genworth 旗下的抵押贷款保险公司 Enact Holdings Inc. 计划发行 1330 万股股票，每股定价为 19 至 20 美元。该公司的估值最高时为 33 亿美元。该公司表示，所有股份将由Genworth出售，不会获得任何收益。该公司已申请在纳斯达克上市，股票代码为 “ACT”。高盛和摩根大通是参与该交易的九家银行团队的主承销商。</blockquote></p><p> •&nbsp;ForgeRock<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>&nbsp;a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.</p><p><blockquote>• 假摇滚<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>总部位于加利福尼亚州的身份安全平台希望通过发行 1100 万股股票来筹集高达 2.64 亿美元的资金，每股价格在 21 美元至 24 美元之间。该定价将使该公司估值高达 19.1 亿美元。</blockquote></p><p> The stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.</p><p><blockquote>该股预计将在纽约证券交易所上市，股票代码为 “FORG ”。摩根士丹利和摩根大通是主承销商。该公司 2020 年收入为 1.276 亿美元，净亏损 4180 万美元，而 2019 年收入为 1.045 亿美元，亏损 3690 万美元。</blockquote></p><p> <b>•</b>Dice Therapeutics&nbsp;is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.</p><p><blockquote><b>•</b>Dice Therapeutics 预计将以高达 5.83 亿美元的估值筹集高达 1.7 亿美元的资金，并在纳斯达克上市，股票代码为 “DICE ”。生物技术正在开发治疗免疫学领域慢性疾病的疗法。</blockquote></p><p> <b>•</b>Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.</p><p><blockquote><b>•</b>手术机器人开发商 Procept BioRobotics 的目标是以约 10 亿美元的估值筹集至多 1.32 亿美元，计划在纳斯达克上市，股票代码为 “PRCT”。美国银行证券和高盛是主承销商。</blockquote></p><p> “We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.</p><p><blockquote>“该公司在 IPO 文件中表示：”我们开发、制造和销售 AquaBeam 机器人系统，这是一种先进的图像引导手术机器人系统，用于微创泌尿外科手术，最初的重点是治疗良性前列腺增生（BPH）。</blockquote></p><p> <b>•</b>Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”</p><p><blockquote><b>•</b>Tyra Biosciences 的目标是以 5.89 亿美元的估值筹集 1.072 亿美元的 IPO 收益。该生物技术公司的主要候选产品是治疗膀胱癌的药物。它已申请在纳斯达克上市，代码为 “泰拉 ”。</blockquote></p><p> <b>•</b>EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.</p><p><blockquote><b>•</b>EzFill Holdings 是一家位于南佛罗里达州的基于应用程序的移动加油公司，计划以 1 亿美元的估值筹集 2500 万美元。该公司已申请在纳斯达克上市，股票代码为 “EZFL”。ThinkEquity 是独家承销商。</blockquote></p><p> The Renaissance IPO ETF&nbsp;has gained 6% to date in 2021, while the S&amp;P 500&nbsp;has advanced 19%.</p><p><blockquote>2021 年迄今为止，Renaissance IPO ETF 上涨了 6%，而标普500上涨了 19%。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的 IPO 市场有望使 2021 年成为有史以来收益最大的一年</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBusy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的 IPO 市场有望使 2021 年成为有史以来收益最大的一年</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-09-14 15:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week </p><p><blockquote>由罗杰·费德勒和得来速咖啡连锁店支持的瑞士跑鞋公司预计将于本周上市</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/18111af5f5bda21b3128860fe616c5ca\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Swiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.</span></p><p><blockquote><p class=\"t-img-caption\"><span>瑞士网球巨人罗杰·费德勒是本周最大的IPO之一的支持者。</span></p></blockquote></p><p> After a flurry of initial-public-offering launches last week&nbsp;set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. </p><p><blockquote>在上周一系列首次公开募股启动让市场陷入繁忙的交易量下跌之后，预计本周将有 11 家公司定价并筹集超过 30 亿美元的收益。</blockquote></p><p> If all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. </p><p><blockquote>机构研究和交易所交易基金提供商 Renaissance Capital 的创始人兼首席执行官比尔·史密斯 (Bill Smith) 表示，如果所有交易都能实现，2021 年将成为有史以来 IPO 收益最大的一年，并打破之前的记录约 30%。据 Renaissance 称，今年市场预计将达成约 375 笔交易，筹集 1250 亿美元，超过 2000 年互联网繁荣时期筹集的 970 亿美元。</blockquote></p><p> “After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. </p><p><blockquote>“史密斯在一篇市场评论中写道：”在漫长的暑假之后，本周是即将到来的科技、生物技术和消费品 IPO 的试金石。这份名单包括一家由网球巨头罗杰·费德勒支持的瑞士跑鞋公司、一家免下车咖啡亭运营商以及一家从保险公司 Genworth Financial 分拆出来的抵押贷款保险公司。</blockquote></p><p> The biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.</p><p><blockquote>本周最大的交易预计将来自总部位于芝加哥的技术咨询公司 Thoughtworks，该公司将以高达 61 亿美元的估值上市。</blockquote></p><p> The company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.</p><p><blockquote>该公司预计在 IPO 完成后将名称从 Turing Holding Corp. 更名为 Thoughtworks，并表示将发行总计 3684 万股股票，分配给公司和出售股东。</blockquote></p><p> The deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.</p><p><blockquote>预计交易价格将在每股 18 美元至 20 美元之间，股票将在纳斯达克交易，股票代码为 “TWKS”。高盛和摩根大通是主承销商。该公司 2020 年收入为 8.034 亿美元，净利润为 7930 万美元，而 2019 年收入为 7.722 亿美元，净利润为 2840 万美元。</blockquote></p><p> The Swiss athletic-footwear maker On Holding&nbsp;is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”</p><p><blockquote>这家持股的瑞士运动鞋制造商预计将以近 60 亿美元的估值筹集高达 6.22 亿美元的资金。On 已申请在纽约证券交易所上市 3110 万股股票，每股定价为 18 至 20 美元，股票代码为 “ONON”。</blockquote></p><p> Goldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.</p><p><blockquote>高盛、摩根士丹利和摩根士丹利是这笔交易的九家银行组成的银团的主承销商。所得款项将用于一般公司用途。该公司有一条与费德勒共同开发的产品线。</blockquote></p><p> The company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period,&nbsp;according to its IPO documents.&nbsp;Sales came to 315.5 million francs, up from 170.9 million francs.</p><p><blockquote>根据其首次公开募股文件，该公司在截至 6 月 30 日的六个月中净利润为 380 万瑞士法郎（约合 410 万美元），而去年同期亏损 3310 万法郎。销售额从 1.709 亿法郎增至 3.155 亿法郎。</blockquote></p><p> Also from Switzerland, sports betting site Sportrader Group AG&nbsp;plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.</p><p><blockquote>同样来自瑞士的体育博彩网站Sportrader Group AG计划发行1900万股股票，每股定价25至28美元，估值高达310亿美元。该公司已申请在纳斯达克上市，股票代码为 “SRAD”。摩根大通、摩根士丹利、花旗集团和瑞银是参与该交易的 13 家银行财团的主承销商。</blockquote></p><p> Proceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million,&nbsp;according to its filing documents.</p><p><blockquote>所得款项将用作营运资金和刺激增长。根据其备案文件，该公司今年前六个月净利润为 2990 万美元，收入为 3.21 亿美元。</blockquote></p><p> Dutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.</p><p><blockquote>Dutch Bros Inc. 是一家主要在美国西部各州提供冷热饮料的免下车商店运营商，计划在 IPO 中发行 2110 万股股票，每股定价为 18 至 20 美元，公司估值高达 33 亿美元。</blockquote></p><p> BofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”</p><p><blockquote>美国银行证券、摩根大通和杰富瑞是参与该交易的 13 家银行财团的主承销商。该公司已申请在纽约证券交易所上市，股票代码为 “BROS.</blockquote></p><p> Proceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.</p><p><blockquote>所得款项将用于购买额外的 A 类股票——该公司计划持有四类具有不同投票权的股票。该公司今年前六个月净亏损 1,360 万美元，即每股亏损 32 美分，低于去年同期公布的 1,650 万美元，即每股亏损 38 美分。收入从 3.274 亿美元降至 2.279 亿美元。</blockquote></p><p> <b>Rounding out the list are:</b></p><p><blockquote><b>最后一个列表是：</b></blockquote></p><p> •&nbsp;Definitive Healthcare Corp.,&nbsp;a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.</p><p><blockquote>- 总部位于马萨诸塞州的医疗保健商业智能提供商 Definitive Healthcare Corp. 计划在其 PO 中发行 1556 万股股票，预计每股价格在 21 至 24 美元之间。按照这个定价，该公司的估值可能高达 35.5 亿美元。</blockquote></p><p></p><p> •&nbsp;Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.</p><p><blockquote>- Genworth 旗下的抵押贷款保险公司 Enact Holdings Inc. 计划发行 1330 万股股票，每股定价为 19 至 20 美元。该公司的估值最高时为 33 亿美元。该公司表示，所有股份将由Genworth出售，不会获得任何收益。该公司已申请在纳斯达克上市，股票代码为 “ACT”。高盛和摩根大通是参与该交易的九家银行团队的主承销商。</blockquote></p><p> •&nbsp;ForgeRock<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>&nbsp;a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.</p><p><blockquote>• 假摇滚<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>总部位于加利福尼亚州的身份安全平台希望通过发行 1100 万股股票来筹集高达 2.64 亿美元的资金，每股价格在 21 美元至 24 美元之间。该定价将使该公司估值高达 19.1 亿美元。</blockquote></p><p> The stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.</p><p><blockquote>该股预计将在纽约证券交易所上市，股票代码为 “FORG ”。摩根士丹利和摩根大通是主承销商。该公司 2020 年收入为 1.276 亿美元，净亏损 4180 万美元，而 2019 年收入为 1.045 亿美元，亏损 3690 万美元。</blockquote></p><p> <b>•</b>Dice Therapeutics&nbsp;is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.</p><p><blockquote><b>•</b>Dice Therapeutics 预计将以高达 5.83 亿美元的估值筹集高达 1.7 亿美元的资金，并在纳斯达克上市，股票代码为 “DICE ”。生物技术正在开发治疗免疫学领域慢性疾病的疗法。</blockquote></p><p> <b>•</b>Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.</p><p><blockquote><b>•</b>手术机器人开发商 Procept BioRobotics 的目标是以约 10 亿美元的估值筹集至多 1.32 亿美元，计划在纳斯达克上市，股票代码为 “PRCT”。美国银行证券和高盛是主承销商。</blockquote></p><p> “We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.</p><p><blockquote>“该公司在 IPO 文件中表示：”我们开发、制造和销售 AquaBeam 机器人系统，这是一种先进的图像引导手术机器人系统，用于微创泌尿外科手术，最初的重点是治疗良性前列腺增生（BPH）。</blockquote></p><p> <b>•</b>Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”</p><p><blockquote><b>•</b>Tyra Biosciences 的目标是以 5.89 亿美元的估值筹集 1.072 亿美元的 IPO 收益。该生物技术公司的主要候选产品是治疗膀胱癌的药物。它已申请在纳斯达克上市，代码为 “泰拉 ”。</blockquote></p><p> <b>•</b>EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.</p><p><blockquote><b>•</b>EzFill Holdings 是一家位于南佛罗里达州的基于应用程序的移动加油公司，计划以 1 亿美元的估值筹集 2500 万美元。该公司已申请在纳斯达克上市，股票代码为 “EZFL”。ThinkEquity 是独家承销商。</blockquote></p><p> The Renaissance IPO ETF&nbsp;has gained 6% to date in 2021, while the S&amp;P 500&nbsp;has advanced 19%.</p><p><blockquote>2021 年迄今为止，Renaissance IPO ETF 上涨了 6%，而标普500上涨了 19%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯","ONON":"On Holding AG","BROS":"Dutch Bros Inc.","SRAD":"Sportradar Group AG",".SPX":"S&P 500 Index","DH":"Definitive Healthcare Corp.","PRCT":"PROCEPT BioRobotics","TYRA":"Tyra Biosciences, Inc."},"source_url":"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160275332","content_text":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week \nSwiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.\n\n\nAfter a flurry of initial-public-offering launches last week set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. \n\nIf all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. \n\n“After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. \n\nThe biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.\nThe company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.\n\nThe deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.\nThe Swiss athletic-footwear maker On Holding is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”\n\nGoldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.\n\nThe company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period, according to its IPO documents. Sales came to 315.5 million francs, up from 170.9 million francs.\n\nAlso from Switzerland, sports betting site Sportrader Group AG plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.\n\nProceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million, according to its filing documents.\n\nDutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.\n\nBofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”\nProceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.\n\nRounding out the list are:\n• Definitive Healthcare Corp., a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.\n• Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.\n• ForgeRock, a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.\nThe stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.\n•Dice Therapeutics is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.\n•Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.\n“We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.\n•Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”\n•EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.\nThe Renaissance IPO ETF has gained 6% to date in 2021, while the S&P 500 has advanced 19%.","news_type":1,"symbols_score_info":{"SRAD":0.9,"TWKS":0.9,".IXIC":0.9,"DRNA":0.9,"TYRA":0.9,"ONON":0.9,"PRCT":0.9,"DH":0.9,".DJI":0.9,"BROS":0.9,".SPX":0.9,"FORG":0.9,"ACT.UK":0.9}},"isVote":1,"tweetType":1,"viewCount":1040,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883739398,"gmtCreate":1631271667914,"gmtModify":1631888993343,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Will consider","listText":"Will consider","text":"Will consider","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883739398","repostId":"2166897344","repostType":4,"isVote":1,"tweetType":1,"viewCount":719,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812593303,"gmtCreate":1630593253402,"gmtModify":1631888993344,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"😂 we can only dream, if that happens I will increase my apple&nbsp;portfolio size to 25%😂","listText":"😂 we can only dream, if that happens I will increase my apple&nbsp;portfolio size to 25%😂","text":"😂 we can only dream, if that happens I will increase my apple portfolio size to 25%😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/812593303","repostId":"1131318558","repostType":4,"repost":{"id":"1131318558","kind":"news","pubTimestamp":1630591645,"share":"https://www.laohunote.com/m/news/1131318558?lang=zh_CN&edition=full","pubTime":"2021-09-02 22:07","market":"us","language":"en","title":"Bear Attack: Could Apple Stock Really Drop 40%?<blockquote>熊市攻击：苹果股票真的会下跌40%吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1131318558","media":"Thestreet","summary":"One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?On the first day of September, one of the rare Wall Street bears on Apple stock  finally gave in and dropped his sell rating. The last remaining one still sees shares dropping to a price target of $90, representing risk of loss of around 40%.Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall ","content":"<p>One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?</p><p><blockquote>两名给予苹果股票卖出评级的华尔街分析师之一认输了。另一位人士仍然认为 AAPL 股价可能会下跌 40%。相当大的下行风险现实吗？</blockquote></p><p> On the first day of September, one of the rare Wall Street bears on Apple stock&nbsp;(<b>AAPL</b>)&nbsp;finally gave in and dropped his sell rating. The last remaining one still&nbsp;sees&nbsp;shares dropping to a price target of $90, representing risk of loss of around 40%.</p><p><blockquote>9月的第一天，华尔街罕见的空头之一苹果股票（<b>苹果</b>）最终屈服并降低了卖出评级。剩下的最后一只股票仍然预计股价将跌至 90 美元的目标价，损失风险约为 40%。</blockquote></p><p> Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.</p><p><blockquote>新街的皮埃尔-费拉古（Pierre Ferragu）是华尔街仅存的苹果熊，他对看涨期权的看法是否正确？这位苹果专家更仔细地研究了这个论点。</blockquote></p><p> <b>Why bearish on Apple?</b></p><p><blockquote><b>为什么看空苹果？</b></blockquote></p><p> The core of Pierre’s bearish argument&nbsp;seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.</p><p><blockquote>皮埃尔看跌论点的核心似乎是 iPhone。这位分析师将即将到来的设备发布称为 “12S 周期”，认为苹果 iPhone 升级浪潮中最精彩的部分，即所谓的 5G 超级周期，已经被抛在了后视镜里。</blockquote></p><p> New Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the&nbsp;opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:</p><p><blockquote>New Street同意这样的观点，即强劲的iPhone 12周期推动了智能手机销售，留下了未来的需求缺口。有趣的是，这与看涨的韦德布什分析师丹·艾夫斯（Dan Ives）的观点完全相反，他在接受苹果专家采访时说道：</blockquote></p><p>   “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”  Still on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.</p><p><blockquote>“华尔街低估的是这个超级周期有多么庞大和漫长。[...]在未来两三年内，5G 不会被完全普及，直到网络建成。在中国（5G 基础设施更加先进），iPhone 12，尤其是更大尺寸的专业版，确实卖得非常好。”Ferragu 先生仍然在 iPhone 上，早在 4 月份就列出了他对 2022 年的期望（我不知道从那时起有任何修订）。他认为 iPhone 出货量将达到 1.9 亿部，这意味着该部门的收入约为 1500 亿美元，比 COVID-19 水平每年小幅增长 5%。</blockquote></p><p> <b>Could AAPL sink 40%?</b></p><p><blockquote><b>苹果能下跌40%吗？</b></blockquote></p><p> Now, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).</p><p><blockquote>现在，让我们动笔。要使苹果股票的估值达到每股 90 美元，需要发生两件事之一：要么财务业绩需要落后于普遍预期，要么估值需要收缩（或两者兼而有之）。</blockquote></p><p> On results,Wall Street currently sees&nbsp;fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.</p><p><blockquote>从业绩来看，华尔街目前预计 2022 财年每股收益将达到 5.63 美元，与迄今为止令人印象深刻的 2021 财年基本持平。因此，AAPL 要想降价 40%，明年的盈利需要大幅低于市场预期，至少低几美元。我觉得这不太可能。</blockquote></p><p> On valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.</p><p><blockquote>根据估值，AAPL 目前的 2021 财年市盈率为 27 倍。假设未来的结果与共识一致，该倍数需要降至 16 倍左右，AAPL 股价才能跌至 90 美元。该股的远期市盈率多年来从未如此之低。</blockquote></p><p> <b>The Apple Maven’s take</b></p><p><blockquote><b>苹果专家的看法</b></blockquote></p><p> I find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.</p><p><blockquote>我发现苹果的估值再次达到每股90美元是非常不可能的，如果不是几乎不可能的话。在我看来，在苹果公司过去六个月上涨了 25% 之后，新街目前对该股的目标价已经过时了，这更合理。</blockquote></p><p> Therefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.</p><p><blockquote>因此，如果华尔街最后一位看空苹果公司的人最终（很快？）屈服于他的下行信念，至少在他目前的目标价方面是这样，我不会感到惊讶。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bear Attack: Could Apple Stock Really Drop 40%?<blockquote>熊市攻击：苹果股票真的会下跌40%吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBear Attack: Could Apple Stock Really Drop 40%?<blockquote>熊市攻击：苹果股票真的会下跌40%吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Thestreet</strong><span class=\"h-time small\">2021-09-02 22:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p>One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?</p><p><blockquote>两名给予苹果股票卖出评级的华尔街分析师之一认输了。另一位人士仍然认为 AAPL 股价可能会下跌 40%。相当大的下行风险现实吗？</blockquote></p><p> On the first day of September, one of the rare Wall Street bears on Apple stock&nbsp;(<b>AAPL</b>)&nbsp;finally gave in and dropped his sell rating. The last remaining one still&nbsp;sees&nbsp;shares dropping to a price target of $90, representing risk of loss of around 40%.</p><p><blockquote>9月的第一天，华尔街罕见的空头之一苹果股票（<b>苹果</b>）最终屈服并降低了卖出评级。剩下的最后一只股票仍然预计股价将跌至 90 美元的目标价，损失风险约为 40%。</blockquote></p><p> Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.</p><p><blockquote>新街的皮埃尔-费拉古（Pierre Ferragu）是华尔街仅存的苹果熊，他对看涨期权的看法是否正确？这位苹果专家更仔细地研究了这个论点。</blockquote></p><p> <b>Why bearish on Apple?</b></p><p><blockquote><b>为什么看空苹果？</b></blockquote></p><p> The core of Pierre’s bearish argument&nbsp;seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.</p><p><blockquote>皮埃尔看跌论点的核心似乎是 iPhone。这位分析师将即将到来的设备发布称为 “12S 周期”，认为苹果 iPhone 升级浪潮中最精彩的部分，即所谓的 5G 超级周期，已经被抛在了后视镜里。</blockquote></p><p> New Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the&nbsp;opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:</p><p><blockquote>New Street同意这样的观点，即强劲的iPhone 12周期推动了智能手机销售，留下了未来的需求缺口。有趣的是，这与看涨的韦德布什分析师丹·艾夫斯（Dan Ives）的观点完全相反，他在接受苹果专家采访时说道：</blockquote></p><p>   “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”  Still on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.</p><p><blockquote>“华尔街低估的是这个超级周期有多么庞大和漫长。[...]在未来两三年内，5G 不会被完全普及，直到网络建成。在中国（5G 基础设施更加先进），iPhone 12，尤其是更大尺寸的专业版，确实卖得非常好。”Ferragu 先生仍然在 iPhone 上，早在 4 月份就列出了他对 2022 年的期望（我不知道从那时起有任何修订）。他认为 iPhone 出货量将达到 1.9 亿部，这意味着该部门的收入约为 1500 亿美元，比 COVID-19 水平每年小幅增长 5%。</blockquote></p><p> <b>Could AAPL sink 40%?</b></p><p><blockquote><b>苹果能下跌40%吗？</b></blockquote></p><p> Now, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).</p><p><blockquote>现在，让我们动笔。要使苹果股票的估值达到每股 90 美元，需要发生两件事之一：要么财务业绩需要落后于普遍预期，要么估值需要收缩（或两者兼而有之）。</blockquote></p><p> On results,Wall Street currently sees&nbsp;fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.</p><p><blockquote>从业绩来看，华尔街目前预计 2022 财年每股收益将达到 5.63 美元，与迄今为止令人印象深刻的 2021 财年基本持平。因此，AAPL 要想降价 40%，明年的盈利需要大幅低于市场预期，至少低几美元。我觉得这不太可能。</blockquote></p><p> On valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.</p><p><blockquote>根据估值，AAPL 目前的 2021 财年市盈率为 27 倍。假设未来的结果与共识一致，该倍数需要降至 16 倍左右，AAPL 股价才能跌至 90 美元。该股的远期市盈率多年来从未如此之低。</blockquote></p><p> <b>The Apple Maven’s take</b></p><p><blockquote><b>苹果专家的看法</b></blockquote></p><p> I find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.</p><p><blockquote>我发现苹果的估值再次达到每股90美元是非常不可能的，如果不是几乎不可能的话。在我看来，在苹果公司过去六个月上涨了 25% 之后，新街目前对该股的目标价已经过时了，这更合理。</blockquote></p><p> Therefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.</p><p><blockquote>因此，如果华尔街最后一位看空苹果公司的人最终（很快？）屈服于他的下行信念，至少在他目前的目标价方面是这样，我不会感到惊讶。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40\">Thestreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131318558","content_text":"One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?\nOn the first day of September, one of the rare Wall Street bears on Apple stock (AAPL) finally gave in and dropped his sell rating. The last remaining one still sees shares dropping to a price target of $90, representing risk of loss of around 40%.\nCould New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.\nWhy bearish on Apple?\nThe core of Pierre’s bearish argument seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.\nNew Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:\n\n “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”\n\nStill on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.\nCould AAPL sink 40%?\nNow, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).\nOn results,Wall Street currently sees fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.\nOn valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.\nThe Apple Maven’s take\nI find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.\nTherefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812051448,"gmtCreate":1630542774584,"gmtModify":1631888993347,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"I scooped in few during the dip.","listText":"I scooped in few during the dip.","text":"I scooped in few during the dip.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/812051448","repostId":"1191563735","repostType":4,"repost":{"id":"1191563735","kind":"news","pubTimestamp":1630542500,"share":"https://www.laohunote.com/m/news/1191563735?lang=zh_CN&edition=full","pubTime":"2021-09-02 08:28","market":"us","language":"en","title":"Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过 7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191563735","media":"Motley Fool","summary":"The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions ","content":"<p>  The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.  <b>What happened</b></p><p><blockquote>美国食品药品监督管理局正在得出合理的结论，但不一定是对消费者非常重要的结论。<b>发生了什么事</b></blockquote></p><p> Shares of drugmaker<b>AbbVie</b>(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.</p><p><blockquote>制药商股份<b>艾伯维</b>（纽约证券交易所股票代码：ABBV）在周三下午的交易时段下跌 7.8%，此前美国食品和药物管理局决定要求在其关节炎治疗药物 Rinvoq 的标签上发布心脏风险警告。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> As part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.</p><p><blockquote>作为临床试验数据常规审查的一部分，FDA 周三宣布，所有在美国获批用于关节炎治疗的 Janus 激酶 (JAK) 抑制剂现在都将在销售时贴上标签，警告其使用者此类药物会增加严重心脏相关事件、癌症、血栓甚至死亡的风险。艾伯维的Rinvoq就是这些抑制JAK的处方药之一。</blockquote></p><p> Blame<b>Pfizer</b>(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.</p><p><blockquote>责怪<b>辉瑞</b>然而（纽约证券交易所股票代码：PFE）。FDA 的决定源于辉瑞关节炎药物 Xeljanz 的数据。这两种药物是围绕相同的JAK抑制方法构建的，在其后期测试中，它被证明会增加血栓和相关心脏问题的风险。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> The knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.</p><p><blockquote>膝跳反应是可以理解的。虽然艾伯维 (AbbVie) 以其关节炎、斑块状牛皮癣和克罗恩病治疗药物修美乐 (Humira) 而闻名，但 Rinvoq 是希望帮助弥补修美乐专利到期带来的销售损失的制药特许经营商之一。</blockquote></p><p> As it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.</p><p><blockquote>但就目前而言，Rinvoq 仅占艾伯维收入的不到 3%，其潜力仍不明朗。这家制药巨头的产品组合中仍有二十多种药物，其中许多药物已经是比 Rinvoq 更大的特许经营权，甚至还有更多药物正在研发中。也没有任何迹象表明关节炎患者会仅仅因为标签上的警告而放弃或避免使用该药物。一旦投资者克服了周三消息的最初冲击，对于已经关注该股的投资者来说，抛售很容易成为买入机会。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过 7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过 7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-09-02 08:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.  <b>What happened</b></p><p><blockquote>美国食品药品监督管理局正在得出合理的结论，但不一定是对消费者非常重要的结论。<b>发生了什么事</b></blockquote></p><p> Shares of drugmaker<b>AbbVie</b>(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.</p><p><blockquote>制药商股份<b>艾伯维</b>（纽约证券交易所股票代码：ABBV）在周三下午的交易时段下跌 7.8%，此前美国食品和药物管理局决定要求在其关节炎治疗药物 Rinvoq 的标签上发布心脏风险警告。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> As part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.</p><p><blockquote>作为临床试验数据常规审查的一部分，FDA 周三宣布，所有在美国获批用于关节炎治疗的 Janus 激酶 (JAK) 抑制剂现在都将在销售时贴上标签，警告其使用者此类药物会增加严重心脏相关事件、癌症、血栓甚至死亡的风险。艾伯维的Rinvoq就是这些抑制JAK的处方药之一。</blockquote></p><p> Blame<b>Pfizer</b>(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.</p><p><blockquote>责怪<b>辉瑞</b>然而（纽约证券交易所股票代码：PFE）。FDA 的决定源于辉瑞关节炎药物 Xeljanz 的数据。这两种药物是围绕相同的JAK抑制方法构建的，在其后期测试中，它被证明会增加血栓和相关心脏问题的风险。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> The knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.</p><p><blockquote>膝跳反应是可以理解的。虽然艾伯维 (AbbVie) 以其关节炎、斑块状牛皮癣和克罗恩病治疗药物修美乐 (Humira) 而闻名，但 Rinvoq 是希望帮助弥补修美乐专利到期带来的销售损失的制药特许经营商之一。</blockquote></p><p> As it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.</p><p><blockquote>但就目前而言，Rinvoq 仅占艾伯维收入的不到 3%，其潜力仍不明朗。这家制药巨头的产品组合中仍有二十多种药物，其中许多药物已经是比 Rinvoq 更大的特许经营权，甚至还有更多药物正在研发中。也没有任何迹象表明关节炎患者会仅仅因为标签上的警告而放弃或避免使用该药物。一旦投资者克服了周三消息的最初冲击，对于已经关注该股的投资者来说，抛售很容易成为买入机会。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/09/01/why-abbvie-is-down-more-than-7-today/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/09/01/why-abbvie-is-down-more-than-7-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191563735","content_text":"The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.\n\nWhat happened\nShares of drugmakerAbbVie(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.\nSo what\nAs part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.\nBlamePfizer(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.\nNow what\nThe knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.\nAs it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.","news_type":1,"symbols_score_info":{"ABBV":0.9}},"isVote":1,"tweetType":1,"viewCount":1089,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816040756,"gmtCreate":1630457373075,"gmtModify":1631888993352,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Will add more once it gets a support.. I believe inthe management.","listText":"Will add more once it gets a support.. I believe inthe management.","text":"Will add more once it gets a support.. I believe inthe management.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/816040756","repostId":"1140744418","repostType":4,"isVote":1,"tweetType":1,"viewCount":1028,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819137040,"gmtCreate":1630042697380,"gmtModify":1704955073874,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","listText":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","text":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/819137040","repostId":"2162090400","repostType":4,"isVote":1,"tweetType":1,"viewCount":1042,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810686066,"gmtCreate":1629971819655,"gmtModify":1631888993359,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"I was thinking of buying, now I will back off 😞","listText":"I was thinking of buying, now I will back off 😞","text":"I was thinking of buying, now I will back off 😞","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810686066","repostId":"1113528238","repostType":4,"isVote":1,"tweetType":1,"viewCount":905,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896478321,"gmtCreate":1628603527063,"gmtModify":1631888993363,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"title":"","htmlText":"To the moon 🚀&nbsp;","listText":"To the moon 🚀&nbsp;","text":"To the moon 🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896478321","repostId":"1181860181","repostType":4,"repost":{"id":"1181860181","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628603123,"share":"https://www.laohunote.com/m/news/1181860181?lang=zh_CN&edition=full","pubTime":"2021-08-10 21:45","market":"us","language":"en","title":"Novavax shares jumped nearly 12% in early trading.<blockquote>Novavax 股价早盘上涨近 12%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1181860181","media":"Tiger Newspress","summary":"Novavax shares jumped nearly 12% in early trading.\nThe New York State Common Retirement Fund, the th","content":"<p>Novavax&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading.</p><p><blockquote>Novavax 股价早盘上涨近 12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e7eaa88109e0546c102a9f6dcce84c43\" tg-width=\"849\" tg-height=\"606\" referrerpolicy=\"no-referrer\">The&nbsp;New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported&nbsp;Barron's.</p><p><blockquote>据《巴伦周刊》报道，美国第三大公共养老金机构纽约州共同退休基金增加了对 Novavax 股票的投资。</blockquote></p><p> The pension also doubled its investment in COVID-19 vaccine play&nbsp;Moderna Inc&nbsp;.</p><p><blockquote>该养老金还将其对 COVID-19 疫苗公司 Moderna Inc. 的投资翻了一番。</blockquote></p><p> The retirement fund also initiated a position in&nbsp;BioNTech SE&nbsp;, the German COVID-19 vaccine partner of&nbsp;Pfizer Inc.</p><p><blockquote>该退休基金还在辉瑞公司的德国 COVID-19 疫苗合作伙伴 BioNTech SE 设立了头寸。</blockquote></p><p> Also on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.</p><p><blockquote>据《马尼拉公报》报道，同样在周一，菲律宾食品药品监督管理局开始评估 Novavax 公司申请其 COVID-19 疫苗的紧急使用授权。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares jumped nearly 12% in early trading.<blockquote>Novavax 股价早盘上涨近 12%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares jumped nearly 12% in early trading.<blockquote>Novavax 股价早盘上涨近 12%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-10 21:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading.</p><p><blockquote>Novavax 股价早盘上涨近 12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e7eaa88109e0546c102a9f6dcce84c43\" tg-width=\"849\" tg-height=\"606\" referrerpolicy=\"no-referrer\">The&nbsp;New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported&nbsp;Barron's.</p><p><blockquote>据《巴伦周刊》报道，美国第三大公共养老金机构纽约州共同退休基金增加了对 Novavax 股票的投资。</blockquote></p><p> The pension also doubled its investment in COVID-19 vaccine play&nbsp;Moderna Inc&nbsp;.</p><p><blockquote>该养老金还将其对 COVID-19 疫苗公司 Moderna Inc. 的投资翻了一番。</blockquote></p><p> The retirement fund also initiated a position in&nbsp;BioNTech SE&nbsp;, the German COVID-19 vaccine partner of&nbsp;Pfizer Inc.</p><p><blockquote>该退休基金还在辉瑞公司的德国 COVID-19 疫苗合作伙伴 BioNTech SE 设立了头寸。</blockquote></p><p> Also on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.</p><p><blockquote>据《马尼拉公报》报道，同样在周一，菲律宾食品药品监督管理局开始评估 Novavax 公司申请其 COVID-19 疫苗的紧急使用授权。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181860181","content_text":"Novavax shares jumped nearly 12% in early trading.\nThe New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported Barron's.\nThe pension also doubled its investment in COVID-19 vaccine play Moderna Inc .\nThe retirement fund also initiated a position in BioNTech SE , the German COVID-19 vaccine partner of Pfizer Inc.\nAlso on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":929,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":812051448,"gmtCreate":1630542774584,"gmtModify":1631888993347,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"I scooped in few during the dip.","listText":"I scooped in few during the dip.","text":"I scooped in few during the dip.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/812051448","repostId":"1191563735","repostType":4,"repost":{"id":"1191563735","kind":"news","pubTimestamp":1630542500,"share":"https://www.laohunote.com/m/news/1191563735?lang=zh_CN&edition=full","pubTime":"2021-09-02 08:28","market":"us","language":"en","title":"Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过 7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191563735","media":"Motley Fool","summary":"The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions ","content":"<p>  The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.  <b>What happened</b></p><p><blockquote>美国食品药品监督管理局正在得出合理的结论，但不一定是对消费者非常重要的结论。<b>发生了什么事</b></blockquote></p><p> Shares of drugmaker<b>AbbVie</b>(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.</p><p><blockquote>制药商股份<b>艾伯维</b>（纽约证券交易所股票代码：ABBV）在周三下午的交易时段下跌 7.8%，此前美国食品和药物管理局决定要求在其关节炎治疗药物 Rinvoq 的标签上发布心脏风险警告。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> As part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.</p><p><blockquote>作为临床试验数据常规审查的一部分，FDA 周三宣布，所有在美国获批用于关节炎治疗的 Janus 激酶 (JAK) 抑制剂现在都将在销售时贴上标签，警告其使用者此类药物会增加严重心脏相关事件、癌症、血栓甚至死亡的风险。艾伯维的Rinvoq就是这些抑制JAK的处方药之一。</blockquote></p><p> Blame<b>Pfizer</b>(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.</p><p><blockquote>责怪<b>辉瑞</b>然而（纽约证券交易所股票代码：PFE）。FDA 的决定源于辉瑞关节炎药物 Xeljanz 的数据。这两种药物是围绕相同的JAK抑制方法构建的，在其后期测试中，它被证明会增加血栓和相关心脏问题的风险。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> The knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.</p><p><blockquote>膝跳反应是可以理解的。虽然艾伯维 (AbbVie) 以其关节炎、斑块状牛皮癣和克罗恩病治疗药物修美乐 (Humira) 而闻名，但 Rinvoq 是希望帮助弥补修美乐专利到期带来的销售损失的制药特许经营商之一。</blockquote></p><p> As it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.</p><p><blockquote>但就目前而言，Rinvoq 仅占艾伯维收入的不到 3%，其潜力仍不明朗。这家制药巨头的产品组合中仍有二十多种药物，其中许多药物已经是比 Rinvoq 更大的特许经营权，甚至还有更多药物正在研发中。也没有任何迹象表明关节炎患者会仅仅因为标签上的警告而放弃或避免使用该药物。一旦投资者克服了周三消息的最初冲击，对于已经关注该股的投资者来说，抛售很容易成为买入机会。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过 7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过 7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-09-02 08:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.  <b>What happened</b></p><p><blockquote>美国食品药品监督管理局正在得出合理的结论，但不一定是对消费者非常重要的结论。<b>发生了什么事</b></blockquote></p><p> Shares of drugmaker<b>AbbVie</b>(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.</p><p><blockquote>制药商股份<b>艾伯维</b>（纽约证券交易所股票代码：ABBV）在周三下午的交易时段下跌 7.8%，此前美国食品和药物管理局决定要求在其关节炎治疗药物 Rinvoq 的标签上发布心脏风险警告。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> As part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.</p><p><blockquote>作为临床试验数据常规审查的一部分，FDA 周三宣布，所有在美国获批用于关节炎治疗的 Janus 激酶 (JAK) 抑制剂现在都将在销售时贴上标签，警告其使用者此类药物会增加严重心脏相关事件、癌症、血栓甚至死亡的风险。艾伯维的Rinvoq就是这些抑制JAK的处方药之一。</blockquote></p><p> Blame<b>Pfizer</b>(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.</p><p><blockquote>责怪<b>辉瑞</b>然而（纽约证券交易所股票代码：PFE）。FDA 的决定源于辉瑞关节炎药物 Xeljanz 的数据。这两种药物是围绕相同的JAK抑制方法构建的，在其后期测试中，它被证明会增加血栓和相关心脏问题的风险。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> The knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.</p><p><blockquote>膝跳反应是可以理解的。虽然艾伯维 (AbbVie) 以其关节炎、斑块状牛皮癣和克罗恩病治疗药物修美乐 (Humira) 而闻名，但 Rinvoq 是希望帮助弥补修美乐专利到期带来的销售损失的制药特许经营商之一。</blockquote></p><p> As it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.</p><p><blockquote>但就目前而言，Rinvoq 仅占艾伯维收入的不到 3%，其潜力仍不明朗。这家制药巨头的产品组合中仍有二十多种药物，其中许多药物已经是比 Rinvoq 更大的特许经营权，甚至还有更多药物正在研发中。也没有任何迹象表明关节炎患者会仅仅因为标签上的警告而放弃或避免使用该药物。一旦投资者克服了周三消息的最初冲击，对于已经关注该股的投资者来说，抛售很容易成为买入机会。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/09/01/why-abbvie-is-down-more-than-7-today/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/09/01/why-abbvie-is-down-more-than-7-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191563735","content_text":"The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.\n\nWhat happened\nShares of drugmakerAbbVie(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.\nSo what\nAs part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.\nBlamePfizer(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.\nNow what\nThe knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.\nAs it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.","news_type":1,"symbols_score_info":{"ABBV":0.9}},"isVote":1,"tweetType":1,"viewCount":1089,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":809227876,"gmtCreate":1627374050595,"gmtModify":1631891947218,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Will add more JD and NIO","listText":"Will add more JD and NIO","text":"Will add more JD and NIO","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/809227876","repostId":"1142907091","repostType":4,"repost":{"id":"1142907091","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627373467,"share":"https://www.laohunote.com/m/news/1142907091?lang=zh_CN&edition=full","pubTime":"2021-07-27 16:11","market":"us","language":"en","title":"Hot Chinese concept stocks resumed downward in premarket trading<blockquote>热门中国概念股在盘前交易中恢复下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142907091","media":"Tiger Newspress","summary":"Hot Chinese concept stocks resumed downward in premarket trading.Bilibili and NetEase fell 7%,DiDi G","content":"<p>Hot Chinese concept stocks resumed downward&nbsp;in premarket trading.Bilibili&nbsp;and&nbsp;NetEase&nbsp;fell&nbsp;7%,DiDi Global,JD.com&nbsp;and&nbsp;Pinduoduo&nbsp;fell&nbsp;6%,Baidu&nbsp;fell&nbsp;5%,Xpeng Motors&nbsp;fell&nbsp;4%,Alibaba,Nio&nbsp;and Li Auto&nbsp;fell&nbsp;3%.</p><p><blockquote>热门中概股在盘前交易中恢复下跌.哔哩哔哩和网易下跌7%，滴滴全球、京东和拼多多下跌6%，百度下跌5%，小鹏汽车下跌4%，阿里巴巴、蔚来和理想汽车下跌3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6d3f423af5595483b1ce34aa42d60cc7\" tg-width=\"355\" tg-height=\"602\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hot Chinese concept stocks resumed downward in premarket trading<blockquote>热门中国概念股在盘前交易中恢复下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHot Chinese concept stocks resumed downward in premarket trading<blockquote>热门中国概念股在盘前交易中恢复下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-27 16:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hot Chinese concept stocks resumed downward&nbsp;in premarket trading.Bilibili&nbsp;and&nbsp;NetEase&nbsp;fell&nbsp;7%,DiDi Global,JD.com&nbsp;and&nbsp;Pinduoduo&nbsp;fell&nbsp;6%,Baidu&nbsp;fell&nbsp;5%,Xpeng Motors&nbsp;fell&nbsp;4%,Alibaba,Nio&nbsp;and Li Auto&nbsp;fell&nbsp;3%.</p><p><blockquote>热门中概股在盘前交易中恢复下跌.哔哩哔哩和网易下跌7%，滴滴全球、京东和拼多多下跌6%，百度下跌5%，小鹏汽车下跌4%，阿里巴巴、蔚来和理想汽车下跌3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6d3f423af5595483b1ce34aa42d60cc7\" tg-width=\"355\" tg-height=\"602\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏集团","BIDU":"百度","BABA":"阿里巴巴","PDD":"拼多多","LI":"理想汽车","JD":"京东","NIO":"蔚来","DIDI":"滴滴(已退市)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142907091","content_text":"Hot Chinese concept stocks resumed downward in premarket trading.Bilibili and NetEase fell 7%,DiDi Global,JD.com and Pinduoduo fell 6%,Baidu fell 5%,Xpeng Motors fell 4%,Alibaba,Nio and Li Auto fell 3%.","news_type":1,"symbols_score_info":{"XPEV":0.9,"LI":0.9,"JD":0.9,"BABA":0.9,"PDD":0.9,"NIO":0.9,"DIDI":0.9,"BIDU":0.9}},"isVote":1,"tweetType":1,"viewCount":640,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819137040,"gmtCreate":1630042697380,"gmtModify":1704955073874,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","listText":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","text":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/819137040","repostId":"2162090400","repostType":4,"isVote":1,"tweetType":1,"viewCount":1042,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805653637,"gmtCreate":1627878175529,"gmtModify":1631891947182,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Will enter when I have an opportunity. SEA is over valued at this time.&nbsp;","listText":"Will enter when I have an opportunity. SEA is over valued at this time.&nbsp;","text":"Will enter when I have an opportunity. SEA is over valued at this time.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/805653637","repostId":"2156741169","repostType":4,"isVote":1,"tweetType":1,"viewCount":819,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898832316,"gmtCreate":1628483153235,"gmtModify":1631884932724,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Amazon and Apple are good buy, am not bullish o n FB considering countries legal restrictions and apple security features&nbsp;","listText":"Amazon and Apple are good buy, am not bullish o n FB considering countries legal restrictions and apple security features&nbsp;","text":"Amazon and Apple are good buy, am not bullish o n FB considering countries legal restrictions and apple security features","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/898832316","repostId":"2157492988","repostType":4,"isVote":1,"tweetType":1,"viewCount":694,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":608507755,"gmtCreate":1638755224231,"gmtModify":1638755224231,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","listText":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","text":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608507755","repostId":"1107533977","repostType":4,"repost":{"id":"1107533977","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638754268,"share":"https://www.laohunote.com/m/news/1107533977?lang=zh_CN&edition=full","pubTime":"2021-12-06 09:31","market":"hk","language":"en","title":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107533977","media":"Tiger Newspress","summary":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.","content":"<p>Li&nbsp;Auto&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;14%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;XPeng&nbsp;fell&nbsp;nearly&nbsp;9%.<img src=\"https://static.tigerbbs.com/f4c63a9e3fe26341f23934616826c6a2\" tg-width=\"747\" tg-height=\"603\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/12cd5c05e050cc41f92f4263ac49921a\" tg-width=\"710\" tg-height=\"606\" width=\"100%\" height=\"auto\"></p><p><blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLi Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 09:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Li&nbsp;Auto&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;14%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;XPeng&nbsp;fell&nbsp;nearly&nbsp;9%.<img src=\"https://static.tigerbbs.com/f4c63a9e3fe26341f23934616826c6a2\" tg-width=\"747\" tg-height=\"603\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/12cd5c05e050cc41f92f4263ac49921a\" tg-width=\"710\" tg-height=\"606\" width=\"100%\" height=\"auto\"></p><p><blockquote>理想汽车股价在香港股市下跌超过14%，小鹏汽车股价下跌近9%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","02015":"理想汽车-W","09868":"小鹏集团-W","XPEV":"小鹏集团"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107533977","content_text":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.","news_type":1,"symbols_score_info":{"LI":0.9,"09868":0.9,"XPEV":0.9,"02015":0.9}},"isVote":1,"tweetType":1,"viewCount":4516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":810686066,"gmtCreate":1629971819655,"gmtModify":1631888993359,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"I was thinking of buying, now I will back off 😞","listText":"I was thinking of buying, now I will back off 😞","text":"I was thinking of buying, now I will back off 😞","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810686066","repostId":"1113528238","repostType":4,"isVote":1,"tweetType":1,"viewCount":905,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800625791,"gmtCreate":1627299814513,"gmtModify":1631891947230,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Waiting for it to dip, I feel it is a value investmentas well","listText":"Waiting for it to dip, I feel it is a value investmentas well","text":"Waiting for it to dip, I feel it is a value investmentas well","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/800625791","repostId":"2154570449","repostType":4,"isVote":1,"tweetType":1,"viewCount":1203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808798343,"gmtCreate":1627609239782,"gmtModify":1631891947193,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Am a beginner, can I enter Amazon now.. guidance please","listText":"Am a beginner, can I enter Amazon now.. guidance please","text":"Am a beginner, can I enter Amazon now.. guidance please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/808798343","repostId":"1105519179","repostType":2,"isVote":1,"tweetType":1,"viewCount":1356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873415599,"gmtCreate":1636975301716,"gmtModify":1636975301716,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"title":"","htmlText":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.&nbsp;","listText":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.&nbsp;","text":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873415599","repostId":"2183046479","repostType":4,"isVote":1,"tweetType":1,"viewCount":4800,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}